| Pacific Fertility Center Los Angeles (PFCLA) | 100.0 | 3 | 3 |
| Texas Fertility Center | 91.7 | 3 | 2 |
| Prelude Fertility | 91.7 | 3 | 2 |
| Pacific Fertility Center | 80.0 | 3 | 1 |
| Fertility Center of San Antonio | 67.5 | 2 | 1 |
| San Diego Fertility Center | 67.5 | 2 | 1 |
| Shady Grove Fertility Center | 67.5 | 2 | 1 |
| Fertility Centers of Illinois | 67.5 | 2 | 1 |
| New Hope Fertility Center | 67.5 | 2 | 1 |
| Progyny, Inc. | 67.5 | 2 | 1 |
| Day of Eight Billion | 60.0 | 3 | 0 |
| March of Dimes | 47.5 | 2 | 0 |
| Europe This Week | 47.5 | 2 | 0 |
| Market Watch | 47.5 | 2 | 0 |
| The Profit | 47.5 | 2 | 0 |
| Colorado Center for Reproductive Medicine | 47.5 | 2 | 0 |
| Sher Fertility | 47.5 | 2 | 0 |
| Pacific Centre for Reproductive Medicine | 47.5 | 2 | 0 |
| Valley Health System | 47.5 | 2 | 0 |
| Back in the Game | 47.5 | 2 | 0 |
| Stanford Children's Health | 47.5 | 2 | 0 |
| fertility clinic | 40.0 | 0 | 3 |
| Money Management International | 40.0 | 0 | 3 |
| assisted reproductive technology | 31.7 | 0 | 2 |
| GoodLeap | 31.7 | 0 | 2 |
| health expenditure | 31.7 | 0 | 2 |
| Financial Counseling and Planning | 31.7 | 0 | 2 |
| The use of complementary and alternative fertility treatment in couples seeking fertility care: data from a prospective cohort in the United States | 31.7 | 0 | 2 |
| In vitromaturation of human oocytes: Its role in infertility treatment and new possibilities | 31.7 | 0 | 2 |
| Fertility clinic, egg donation agency, and sperm bank policies | 31.7 | 0 | 2 |
| Fertility treatments and outcomes among couples seeking fertility care: data from a prospective fertility cohort in the United States | 31.7 | 0 | 2 |
| Consistency in insurance coverage for iatrogenic conditions resulting from cancer treatment including fertility preservation | 31.7 | 0 | 2 |
| Optimal timing for elective egg freezing | 31.7 | 0 | 2 |
| A global perspective on assisted reproductive technology fertility treatment: an 8-country fertility specialist survey | 31.7 | 0 | 2 |
| Single thawed euploid embryo transfer improves IVF pregnancy, miscarriage, and multiple gestation outcomes and has similar implantation rates as egg donation. | 31.7 | 0 | 2 |
| U.S. physicians' views on financing options to expand health insurance coverage: a national survey | 31.7 | 0 | 2 |
| Limb-body wall complex in one fetus of a dizygotic twin pregnancy conceived by egg donation, in vitro fertilization and embryo transfer: prenatal diagnosis and literature review | 31.7 | 0 | 2 |
| Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review | 31.7 | 0 | 2 |
| Fertility preservation and infertility treatment in breast cancer patients | 31.7 | 0 | 2 |
| Multiple gestations/pregnancies from IVF process in a fertility center in Nigeria, 2009-2011: implementing policy towards fewer (double and single) embryo transfer | 31.7 | 0 | 2 |
| Fertility Treatment Decision-Making: The Effect of Insurance Coverage for Fertility Medications | 31.7 | 0 | 2 |
| Ovarian stem cells—Potential roles in infertility treatment and fertility preservation | 31.7 | 0 | 2 |
| Lesbian, gay, bisexual, transgender content on reproductive endocrinology and infertility clinic websites | 31.7 | 0 | 2 |
| Embryo transfer simulation improves pregnancy rates and decreases time to proficiency in Reproductive Endocrinology and Infertility fellow embryo transfers | 31.7 | 0 | 2 |
| Practice patterns, satisfaction, and demographics of reproductive endocrinologists: results of the 2014 Society for Reproductive Endocrinology and Infertility Workforce Survey | 31.7 | 0 | 2 |
| Determining the need for rescue intracytoplasmic sperm injection in partial fertilisation failure during a conventional IVF cycle | 31.7 | 0 | 2 |
| Lapse in embryo transfer training does not negatively affect clinical pregnancy rates for reproductive endocrinology and infertility fellows | 31.7 | 0 | 2 |
| IVF Treatment and Single Embryo Transfer | 31.7 | 0 | 2 |
| Usage of herbal medications in patients undergoing IVF treatment in an Irish infertility treatment unit | 31.7 | 0 | 2 |
| The serum concentration of estradiol after embryo transfer and the decline from preovulatory levels may influence the success of IVF treatment | 31.7 | 0 | 2 |
| Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer | 31.7 | 0 | 2 |
| Embryo transfer by reproductive endocrinology fellows vs attending physicians: are live birth rates comparable? | 31.7 | 0 | 2 |
| First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient | 31.7 | 0 | 2 |
| Out-of-Pocket Costs and Insurance Coverage for Abortion in the United States | 31.7 | 0 | 2 |
| Association of Prior Authorization and Out-of-pocket Costs With Patient Access to PCSK9 Inhibitor Therapy | 31.7 | 0 | 2 |
| Evolution of a reproductive endocrinologist: the Society for Reproductive Endocrinology and Infertility fellows retreat and preliminary results of manpower survey | 31.7 | 0 | 2 |
| Factors associated with dizygotic twinning after IVF treatment with double embryo transfer | 31.7 | 0 | 2 |
| Medical egg freezing: the importance of a patient-centered approach to fertility preservation | 31.7 | 0 | 2 |
| Medical egg freezing and cancer patients' hopes: Fertility preservation at the intersection of life and death | 31.7 | 0 | 2 |
| Reproductive Ethics in Commercial Surrogacy: Decision-Making in IVF Clinics in New Delhi, India | 31.7 | 0 | 2 |
| Cryopreserved embryo transfer: adjacent or non-adjacent to failed fresh long GnRH-agonist protocol IVF cycle | 31.7 | 0 | 2 |
| Parameters that influence the results of in vitro fertilization/embryo transfer: a study of an egg donation model | 31.7 | 0 | 2 |
| Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism | 31.7 | 0 | 2 |
| Single embryo implantation per IVF cycle: the answer to every request for assisted reproduction? | 31.7 | 0 | 2 |
| Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers | 31.7 | 0 | 2 |
| Efficacy of intrauterine inseminations as a training modality for performing embryo transfer in reproductive endocrinology and infertility fellowship programs. | 31.7 | 0 | 2 |
| Clinical outcomes and treatment cost comparison of levalbuterol versus albuterol in hospitalized adults with chronic obstructive pulmonary disease or asthma | 31.7 | 0 | 2 |
| Anti-Müllerian hormone levels after laparoscopic cystectomy for endometriomas as a possible predictor for pregnancy in infertility treatments | 31.7 | 0 | 2 |
| The politics of reproductive benefits: U.S. insurance coverage of contraceptive and infertility treatments | 31.7 | 0 | 2 |
| Distributive justice and the regulation of fertility centers: an analysis of the Fertility Clinic Success Rate and Certification Act. | 31.7 | 0 | 2 |
| A cost comparison of infertility treatment for clomiphene resistant polycystic ovary syndrome | 31.7 | 0 | 2 |
| Comparison of the effect of immediate versus delayed transfer following a stimulated IVF cycle on the ongoing pregnancy rate of frozen-thawed embryo transfer cycles: a study protocol for a randomised controlled trial. | 31.7 | 0 | 2 |
| Reply: Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer | 31.7 | 0 | 2 |
| Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence? | 31.7 | 0 | 2 |
| THE OPTIMAL INTERVAL OF TIME FROM OPERATIVE HYSTEROSCOPY TO EMBRYO TRANSFER IN AN IVF CYCLE | 31.7 | 0 | 2 |
| Egg freezing for fertility preservation and family planning: a nationwide survey of US Obstetrics and Gynecology residents | 31.7 | 0 | 2 |
| The Effect of Embryo Culture Under Low Oxygen Tension on Pregnancy Rates | 31.7 | 0 | 2 |
| Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics | 31.7 | 0 | 2 |
| Intracytoplasmic sperm injection use in states with and without insurance coverage mandates for infertility treatment, United States, 2000-2015 | 31.7 | 0 | 2 |
| A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment | 31.7 | 0 | 2 |
| Bed Rest or no Bed Rest? | 31.7 | 0 | 2 |
| EmbryoGlue as an Embryo Transfer Medium | 31.7 | 0 | 2 |
| Embryotransfer Operator and Pregnancy Rate | 31.7 | 0 | 2 |
| Predictive Value of Mid-luteal Serum Progesterone Levels in Egg Donation Cycles | 31.7 | 0 | 2 |
| Immediate Versus Delayed FET Following a Stimulated IVF Cycle | 31.7 | 0 | 2 |
| Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment | 31.7 | 0 | 2 |
| Comparison of Embryo Transfer in Egg Donation Recipients With Transvaginal and Transabdominal Ultrasound | 31.7 | 0 | 2 |
| Infertility treatment dropout and insurance coverage | 31.7 | 0 | 2 |
| Infertility and the ADA: health insurance coverage for infertility treatment | 31.7 | 0 | 2 |
| Infertility treatment and informed consent: current practices of reproductive endocrinologists | 31.7 | 0 | 2 |
| Would legislation imposing single embryo transfer be a feasible way to reduce the rate of multiple pregnancies after IVF treatment? | 31.7 | 0 | 2 |
| Single embryo transfer in IVF treatment | 31.7 | 0 | 2 |
| Reproductive endocrinology: Infertility treatment in PCOS--is metformin in from the cold? | 31.7 | 0 | 2 |
| Insurance Coverage and Aid-in-Dying Medication Costs | 31.7 | 0 | 2 |
| Insurance Coverage and Aid-in-Dying Medication Costs-Reply | 31.7 | 0 | 2 |
| Treatment Cost Comparison: Paliperidone Palmitate Versus Risperidone Long Acting in Brazil | 31.7 | 0 | 2 |
| The effect of fresh IVF cycle characteristics on frozen embryo transfer (FET) outcomes | 31.7 | 0 | 2 |
| Elective Single Embryo Transfer in the Setting of Funded In Vitro Fertilization: Two Years' Experience in an Ontario Hospital-Based Fertility Clinic | 31.7 | 0 | 2 |
| Luteal-phase progesterone supplementation in non-IVF treatment: a survey of physicians providing infertility treatment | 31.7 | 0 | 2 |
| Influence of surgical evacuation on pregnancy outcomes of subsequent embryo transfer cycle following miscarriage in an initial IVF cycle: a retrospective cohort study | 31.7 | 0 | 2 |
| The ethics of fertility treatment for same-sex male couples: Considerations for a modern fertility clinic | 31.7 | 0 | 2 |
| EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists | 31.7 | 0 | 2 |
| Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer | 31.7 | 0 | 2 |
| Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer-Reply | 31.7 | 0 | 2 |
| Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome | 31.7 | 0 | 2 |
| Elective egg freezing and male support: a qualitative study of men's roles in women's fertility preservation | 31.7 | 0 | 2 |
| A Randomized Trial Comparing the Live Birth Rate of Immediate Versus Delayed Frozen Embryo Transfer (FET) Following a Freeze-all Strategy | 31.7 | 0 | 2 |
| Attitudes and experiences of health care professionals when caring for transgender men undergoing fertility preservation by egg freezing: a qualitative study | 31.7 | 0 | 2 |
| Aneuploid embryo transfer: clinical policies and provider opinions at United States fertility clinics | 31.7 | 0 | 2 |
| Single Embryo Transfer Versus Double Embryo Transfer: A Cost-Effectiveness Analysis in a Non-IVF Insurance Mandated System | 31.7 | 0 | 2 |
| Follicular fluid anti-Müllerian hormone (AMH) concentrations and outcomes of in vitro fertilization cycles with fresh embryo transfer among women at a fertility center | 31.7 | 0 | 2 |
| Gender-specific aspects related to type of fertility preservation strategies and access to fertility care | 31.7 | 0 | 2 |
| The marketing of elective egg freezing: A content, cost and quality analysis of UK fertility clinic websites | 31.7 | 0 | 2 |
| Outcome of mock embryo transfer before the first IVF cycle: A randomized control trial | 31.7 | 0 | 2 |
| Experiences of women undergoing infertility treatment from embryo transfer until pregnancy test and their conceptualization of their embryo | 31.7 | 0 | 2 |
| Women’s preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policy | 31.7 | 0 | 2 |
| Efficacy and Safety of Fertility Treatments and Fertility Preservation | 31.7 | 0 | 2 |
| Analysis of the Composition of the Vaginal Microbiota During IVF Treatment and Correlation With Serum Progesterone Level on the Day of Embryo Transfer | 31.7 | 0 | 2 |
| Primary and secondary municipal wastewater treatment cost comparison | 31.7 | 0 | 2 |
| KINDERWUNSCHZENTRUM LOS ANGELES, INC. | 31.7 | 0 | 2 |
| Impact of insurance coverage for fertility treatment on patient preference for singleton gestation | 31.7 | 0 | 2 |
| Elective egg freezing and male support: a qualitative study of men’s hidden roles in women’s fertility preservation | 31.7 | 0 | 2 |
| Association between the number of oocytes retrieved and cumulative live birth rate in IVF treatment: menopur in GnRH antagonist single embryo transfer - high responder (MEGASET-HR) trial outcomes | 31.7 | 0 | 2 |
| Recent Advances in Reproductive Endocrinology: Implications for Fertility Treatment in Gynecology | 31.7 | 0 | 2 |
| "Assessing Xolair (Omalizumab) Utilization and Insurance Coverage Challenges in Idiopathic Urticaria: A Retrospective Analysis of Patient Outcomes and Prior Authorization Delays" | 31.7 | 0 | 2 |
| Obstetric and Perinatal Outcomes of Pregnancies After Infertility Treatment Using Assisted Reproductive Technologies With Cryopreserved Embryo Transfer | 31.7 | 0 | 2 |
| Egg freezing for fertility preservation and family planning: a survey of OB/GYN residents across united states | 31.7 | 0 | 2 |
| Anti-mullerian hormone level as a predictor of ovarian reserve in patients seeking fertility preservation versus infertility treatment | 31.7 | 0 | 2 |
| The gift of motherhood: Egg donation in a Barcelona infertility clinic | 31.7 | 0 | 2 |
| Cryopreserving Jewish Motherhood: Egg Freezing in Israel and the United States | 31.7 | 0 | 2 |
| Cyprus Fertina IVF Clinic | 31.7 | 0 | 2 |
| From scarcity to sisterhood: The framing of egg donation on fertility clinic websites in the UK, Belgium and Spain | 31.7 | 0 | 2 |
| Genesis Fertility Center | 31.7 | 0 | 2 |
| GYN-FIV a.s. | 31.7 | 0 | 2 |
| Aetna | 30.0 | 1 | 0 |
| March of Dimes Prize in Developmental Biology | 30.0 | 1 | 0 |
| American Society for Reproductive Medicine | 30.0 | 1 | 0 |
| United Nations Population Fund | 30.0 | 1 | 0 |
| Thermo Fisher Scientific Inc. | 30.0 | 1 | 0 |
| World Population Day | 30.0 | 1 | 0 |
| Q1023911 | 30.0 | 1 | 0 |
| CNBC | 30.0 | 1 | 0 |
| Applied Biosystems | 30.0 | 1 | 0 |
| Squawk Box | 30.0 | 1 | 0 |
| Worldwide Exchange | 30.0 | 1 | 0 |
| Squawk on the Street | 30.0 | 1 | 0 |
| Power Lunch | 30.0 | 1 | 0 |
| Closing Bell | 30.0 | 1 | 0 |
| Q4261093 | 30.0 | 1 | 0 |
| Affymetrix GeneChip Operating Software | 30.0 | 1 | 0 |
| American Greed | 30.0 | 1 | 0 |
| Aurora Health Care | 30.0 | 1 | 0 |
| Capital Connection | 30.0 | 1 | 0 |
| David Faber | 30.0 | 1 | 0 |
| Emory Healthcare | 30.0 | 1 | 0 |
| Emory University Hospital | 30.0 | 1 | 0 |
| Emory University Hospital Midtown | 30.0 | 1 | 0 |
| Fast Money | 30.0 | 1 | 0 |
| Foreign Exchange | 30.0 | 1 | 0 |
| Highland Hospital | 30.0 | 1 | 0 |
| Lucile Packard Children's Hospital | 30.0 | 1 | 0 |
| Mad Money | 30.0 | 1 | 0 |
| NYU Langone Health | 30.0 | 1 | 0 |
| Nicholas H Noyes Memorial Hospital | 30.0 | 1 | 0 |
| On the Money | 30.0 | 1 | 0 |
| Pierce Biotechnology | 30.0 | 1 | 0 |
| Regenstrief Institute | 30.0 | 1 | 0 |
| Saint Joseph's Hospital | 30.0 | 1 | 0 |
| Street Signs | 30.0 | 1 | 0 |
| Strong Memorial Hospital | 30.0 | 1 | 0 |
| The Kudlow Report | 30.0 | 1 | 0 |
| The Valley Hospital | 30.0 | 1 | 0 |
| On the Money | 30.0 | 1 | 0 |
| Trash Inc: The Secret Life of Garbage | 30.0 | 1 | 0 |
| University of Rochester Medical Center | 30.0 | 1 | 0 |
| Day of Six Billion | 30.0 | 1 | 0 |
| Morning Call | 30.0 | 1 | 0 |
| SYPRO Ruby | 30.0 | 1 | 0 |
| Secret Lives of the Super Rich | 30.0 | 1 | 0 |
| West Texas Investors Club | 30.0 | 1 | 0 |
| Joseph John Klimek | 30.0 | 1 | 0 |
| AMA Journal of Ethics | 30.0 | 1 | 0 |
| United Nations Population Award | 30.0 | 1 | 0 |
| Day of Seven Billion | 30.0 | 1 | 0 |
| London Women's Clinic | 30.0 | 1 | 0 |
| GenesisCare | 30.0 | 1 | 0 |
| The Deed | 30.0 | 1 | 0 |
| Thermo Fisher (Israel) | 30.0 | 1 | 0 |
| Adventure Capitalists | 30.0 | 1 | 0 |
| Hartmut Land | 30.0 | 1 | 0 |
| Emory Rehabilitation Hospital | 30.0 | 1 | 0 |
| Barcelona IVI Clinic | 30.0 | 1 | 0 |
| IVI Madrid Clinic | 30.0 | 1 | 0 |
| IVI Sevilla Clinic | 30.0 | 1 | 0 |
| IVI Valencia Clinic | 30.0 | 1 | 0 |
| Boston IVF | 30.0 | 1 | 0 |
| Aurora Medical Center | 30.0 | 1 | 0 |
| Florida Fertility Institute | 30.0 | 1 | 0 |
| Igenomix | 30.0 | 1 | 0 |
| Seattle Reproductive Medicine | 30.0 | 1 | 0 |
| Reproductive Medicine Associates of New York | 30.0 | 1 | 0 |
| Aurora Sinai Medical Center | 30.0 | 1 | 0 |
| Center for Human Reproduction | 30.0 | 1 | 0 |
| Reproductive Medicine Associates of New Jersey | 30.0 | 1 | 0 |
| Valencian Infertility Institute | 30.0 | 1 | 0 |
| Emory Clinic | 30.0 | 1 | 0 |
| Golisano Children's Hospital | 30.0 | 1 | 0 |
| U.S. News & World Report Best Hospitals Rankings | 30.0 | 1 | 0 |
| GoodRx | 30.0 | 1 | 0 |
| Gigi Fernández | 20.0 | 0 | 1 |
| embryo transfer | 20.0 | 0 | 1 |
| Health Insurance Portability and Accountability Act | 20.0 | 0 | 1 |
| Saudi Aramco | 20.0 | 0 | 1 |
| cost estimate | 20.0 | 0 | 1 |
| SABIC | 20.0 | 0 | 1 |
| hire purchase | 20.0 | 0 | 1 |
| egg donation | 20.0 | 0 | 1 |
| assumption of cover | 20.0 | 0 | 1 |
| Q1362389 | 20.0 | 0 | 1 |
| Cyberpunk 2077 | 20.0 | 0 | 1 |
| Vitrification (ovocytes) | 20.0 | 0 | 1 |
| Buy-up coverage | 20.0 | 0 | 1 |
| California Insurance Equality Act | 20.0 | 0 | 1 |
| Endocrinology of reproduction | 20.0 | 0 | 1 |
| fertility preservation | 20.0 | 0 | 1 |
| fertility tourism | 20.0 | 0 | 1 |
| flood insurance | 20.0 | 0 | 1 |
| health insurance coverage in the United States | 20.0 | 0 | 1 |
| Human Fertilisation and Embryology (Deceased Fathers) Act 2003 | 20.0 | 0 | 1 |
| IT cost transparency | 20.0 | 0 | 1 |
| list of countries by health insurance coverage | 20.0 | 0 | 1 |
| Medicare Advantage | 20.0 | 0 | 1 |
| Medicare Part D coverage gap | 20.0 | 0 | 1 |
| Personal injury protection | 20.0 | 0 | 1 |
| medical costs | 20.0 | 0 | 1 |
| Reproductive endocrinology | 20.0 | 0 | 1 |
| semen collection | 20.0 | 0 | 1 |
| Slovenian fertility treatment referendum, 2001 | 20.0 | 0 | 1 |
| treatment cost | 20.0 | 0 | 1 |
| financial counseling | 20.0 | 0 | 1 |
| Q12306678 | 20.0 | 0 | 1 |
| Akanksha Infertility Clinic | 20.0 | 0 | 1 |
| reproductive endocrinology and infertility | 20.0 | 0 | 1 |
| prior authorization | 20.0 | 0 | 1 |
| $158 billion missing in U.S. Medicare drug benefit cost estimate | 20.0 | 0 | 1 |
| Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies | 20.0 | 0 | 1 |
| cost breakdown analysis | 20.0 | 0 | 1 |
| Online CBT I: Bridging the Gap Between Eliza and Modern Online CBT Treatment Packages | 20.0 | 0 | 1 |
| Consensus on infertility treatment related to polycystic ovary syndrome | 20.0 | 0 | 1 |
| An historical look at embryo transfer | 20.0 | 0 | 1 |
| Peter C. Klatsky | 20.0 | 0 | 1 |
| Clinical adaptation of the sperm ubiquiting tag immunoassay (SUTI): relationship of sperm ubiquitylation with sperm quality in gradient-purified semen samples from 93 men from a general infertility clinic population | 20.0 | 0 | 1 |
| The association of bisphenol-A urinary concentrations with antral follicle counts and other measures of ovarian reserve in women undergoing infertility treatments | 20.0 | 0 | 1 |
| Impact of state mandatory insurance coverage on the use of diabetes preventive care | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer) | 20.0 | 0 | 1 |
| Strategies for expanding health insurance coverage in vulnerable populations | 20.0 | 0 | 1 |
| Vasodilators for women undergoing fertility treatment | 20.0 | 0 | 1 |
| Post-embryo transfer interventions for assisted reproduction technology cycles | 20.0 | 0 | 1 |
| Conservative treatments in gynaecological cancer for fertility preservation | 20.0 | 0 | 1 |
| Adherence compounds in embryo transfer media for assisted reproductive technologies | 20.0 | 0 | 1 |
| Antibiotics prior to embryo transfer in ART | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 20.0 | 0 | 1 |
| Immune therapies for women with history of failed implantation undergoing IVF treatment | 20.0 | 0 | 1 |
| Adherence compounds in embryo transfer media for assisted reproductive technologies | 20.0 | 0 | 1 |
| Antibiotics prior to embryo transfer in ART | 20.0 | 0 | 1 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation | 20.0 | 0 | 1 |
| Outreach strategies for expanding health insurance coverage in children | 20.0 | 0 | 1 |
| Conservative treatments in gynaecological cancer for fertility preservation | 20.0 | 0 | 1 |
| Techniques for preparation prior to embryo transfer | 20.0 | 0 | 1 |
| Techniques for preparation prior to embryo transfer | 20.0 | 0 | 1 |
| Post-embryo transfer interventions for in vitro fertilization and intracytoplasmic sperm injection patients | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes | 20.0 | 0 | 1 |
| Outreach strategies for expanding health insurance coverage in children | 20.0 | 0 | 1 |
| Hyaluronic Acid inclusion in embryo transfer media for assisted reproductive technologies | 20.0 | 0 | 1 |
| Cycle regimens for frozen-thawed embryo transfer | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 20.0 | 0 | 1 |
| Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes | 20.0 | 0 | 1 |
| Soft versus firm embryo transfer catheters for assisted reproductive technology | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted conception | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Post embryo transfer interventions for in vitro fertilization / intracytoplasmic sperm injection patients | 20.0 | 0 | 1 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 20.0 | 0 | 1 |
| Day 3 versus day 2 embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 20.0 | 0 | 1 |
| Health insurance coverage of immigrants living in the United States: differences by citizenship status and country of origin | 20.0 | 0 | 1 |
| Barriers to patient-physician communication about out-of-pocket costs | 20.0 | 0 | 1 |
| Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation | 20.0 | 0 | 1 |
| State Medicaid programs did not make use of prior authorization to promote safer prescribing after rosiglitazone warning | 20.0 | 0 | 1 |
| Frozen-thawed embryo transfer cycles: clinical outcomes of single and double blastocyst transfers | 20.0 | 0 | 1 |
| Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment | 20.0 | 0 | 1 |
| Urinary bisphenol A concentrations in relation to serum thyroid and reproductive hormone levels in men from an infertility clinic | 20.0 | 0 | 1 |
| Infertility, infertility treatment, and congenital malformations: Danish national birth cohort | 20.0 | 0 | 1 |
| Ectopic pregnancy rates with day 3 versus day 5 embryo transfer: a retrospective analysis | 20.0 | 0 | 1 |
| First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy | 20.0 | 0 | 1 |
| Monochorionic-triamniotic triplet pregnancy after intracytoplasmic sperm injection, assisted hatching, and two-embryo transfer: first reported case following IVF | 20.0 | 0 | 1 |
| Toward estimating the impact of changes in immigrants' insurance eligibility on hospital expenditures for uncompensated care | 20.0 | 0 | 1 |
| Journal of Experimental & Clinical Assisted Reproduction: shaping the future of research and practice in reproductive endocrinology/infertility | 20.0 | 0 | 1 |
| Evaluation of adjunctive HPV testing by Hybrid Capture II®in women with minor cytological abnormalities for the diagnosis of CIN2/3 and cost comparison with colposcopy | 20.0 | 0 | 1 |
| Identification and isolation of embryonic stem cells in reproductive endocrinology: theoretical protocols for conservation of human embryos derived from in vitro fertilization | 20.0 | 0 | 1 |
| The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment | 20.0 | 0 | 1 |
| Lack of insurance coverage and urgent care use for asthma: a retrospective cohort study | 20.0 | 0 | 1 |
| Cost estimate for dewatering Alaskan placer effluents with peo | 20.0 | 0 | 1 |
| Cost Estimate of the Bayer Process for Producing Alumina - Based on 1982 Equipment Prices | 20.0 | 0 | 1 |
| Nickel recovery from western sources.Task II. Pilot plant conceptual design and cost estimate | 20.0 | 0 | 1 |
| Preliminary design and cost estimate for field worthy simple featured Mmrdm based on a prototype beta attenuation/filter tape system developed under contract number H0166097 | 20.0 | 0 | 1 |
| Cost comparison of gob hole and cross-measure borehole systems to control methane in gobs | 20.0 | 0 | 1 |
| Multiple zone mining beneficiation of western phosphate rock. A cost estimate and comparison with selective mining | 20.0 | 0 | 1 |
| A cost comparison of selected U.S. and Polish coal mines | 20.0 | 0 | 1 |
| A cost comparison of selected U.S. and Venezuelan coal mines | 20.0 | 0 | 1 |
| A cost comparison of selected U.S. and Indonesian coal mines | 20.0 | 0 | 1 |
| A cost comparison of selected coal mines from Australia | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 20.0 | 0 | 1 |
| Cryopreservation of testicular tissue or testicular cell suspensions: a pivotal step in fertility preservation | 20.0 | 0 | 1 |
| Resurgence of Minimal Stimulation In Vitro Fertilization with A Protocol Consisting of Gonadotropin Releasing Hormone-Agonist Trigger and Vitrified-Thawed Embryo Transfer | 20.0 | 0 | 1 |
| Fertility preservation in women with cervical, endometrial or ovarian cancers | 20.0 | 0 | 1 |
| Fertility Preservation: A Key Survivorship Issue for Young Women with Cancer | 20.0 | 0 | 1 |
| Models Predicting Success of Infertility Treatment: A Systematic Review | 20.0 | 0 | 1 |
| Risks of spontaneously and IVF-conceived singleton and twin pregnancies differ, requiring reassessment of statistical premises favoring elective single embryo transfer (eSET) | 20.0 | 0 | 1 |
| Surgical treatment for hydrosalpinx prior to in-vitro fertilization embryo transfer: a network meta-analysis | 20.0 | 0 | 1 |
| Fertility treatment in spinal cord injury and other neurologic disease | 20.0 | 0 | 1 |
| Fertility preservation in young patients with cancer | 20.0 | 0 | 1 |
| Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled? | 20.0 | 0 | 1 |
| Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women | 20.0 | 0 | 1 |
| Spermatogonial stem cells as a therapeutic alternative for fertility preservation of prepubertal boys | 20.0 | 0 | 1 |
| Fertility preservation for boys and adolescents facing sterilizing medical therapy | 20.0 | 0 | 1 |
| Clinical determinants of mental disorders occurring during the infertility treatment | 20.0 | 0 | 1 |
| Recommendation to Reduce Patients' Blood Pressure and Cholesterol Medication Costs | 20.0 | 0 | 1 |
| Reducing Medication Costs to Prevent Cardiovascular Disease: A Community Guide Systematic Review | 20.0 | 0 | 1 |
| Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia | 20.0 | 0 | 1 |
| Selective Regulation of Oocyte Meiotic Events Enhances Progress in Fertility Preservation Methods | 20.0 | 0 | 1 |
| Fertility preservation during cancer treatment: clinical guidelines | 20.0 | 0 | 1 |
| Fertility Sparing Surgery in Gynecologic Cancer | 20.0 | 0 | 1 |
| Neonatal outcomes among singleton births after blastocyst versus cleavage stage embryo transfer: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Modern radiation therapy and potential fertility preservation strategies in patients with cervical cancer undergoing chemoradiation | 20.0 | 0 | 1 |
| Reproduction and Breast Cancer Risk | 20.0 | 0 | 1 |
| <i>In vitro</i> fertilization in Japan — Early days of <i>in vitro</i> fertilization and embryo transfer and future prospects for assisted reproductive technology — | 20.0 | 0 | 1 |
| Strategies for Fertility Preservation in Young Patients with Cancer: A Comprehensive Approach | 20.0 | 0 | 1 |
| Fertility preservation in young patients′ with cancer | 20.0 | 0 | 1 |
| The longer-term health outcomes for children born as a result of IVF treatment. Part II-Mental health and development outcomes | 20.0 | 0 | 1 |
| How much does that treatment cost? | 20.0 | 0 | 1 |
| Preservation of ovarian function during chemotherapy and radiotherapy in young women with malignancies | 20.0 | 0 | 1 |
| Mary Barton | 20.0 | 0 | 1 |
| Fertility preservation in cancer women: a multidisciplinary approach | 20.0 | 0 | 1 |
| Journal of in vitro fertilization and embryo transfer : IVF | 20.0 | 0 | 1 |
| Seminars in reproductive endocrinology | 20.0 | 0 | 1 |
| Surgical Aspects of Ovarian Tissue Removal and Ovarian Tissue Transplantation for Fertility Preservation | 20.0 | 0 | 1 |
| Ovarian tissue transport to expand access to fertility preservation: from animals to clinical practice | 20.0 | 0 | 1 |
| Abdominal ectopic pregnancy after in vitro fertilization and single embryo transfer: a case report and systematic review | 20.0 | 0 | 1 |
| Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review | 20.0 | 0 | 1 |
| Trends in Insurance Coverage and Treatment Utilization by Young Adults | 20.0 | 0 | 1 |
| Methods for endometrial preparation in frozen-thawed embryo transfer cycles | 20.0 | 0 | 1 |
| Debating Elective Single Embryo Transfer after in vitro Fertilization: A Plea for a Context-Sensitive Approach | 20.0 | 0 | 1 |
| Examining the evidence: progesterone supplementation during fresh and frozen embryo transfer | 20.0 | 0 | 1 |
| Biobanking efforts and new advances in male fertility preservation for rare and endangered species | 20.0 | 0 | 1 |
| Progestins in the Fertility-Sparing Treatment and Retreatment of Patients With Primary and Recurrent Endometrial Cancer | 20.0 | 0 | 1 |
| Identifying and Addressing the Needs of Adolescents and Young Adults With Cancer: Summary of an Institute of Medicine Workshop | 20.0 | 0 | 1 |
| Hysteroscopic cervical canal shaving: a new therapy for cervical stenosis before embryo transfer in patients undergoing in vitro fertilization | 20.0 | 0 | 1 |
| Patient-physician communication about out-of-pocket costs | 20.0 | 0 | 1 |
| Effects of co-administration of growth hormone(GH) and aspirin to women during in vitro fertilization and embryo transfer (IVF-ET) cycles | 20.0 | 0 | 1 |
| John Zhang | 20.0 | 0 | 1 |
| Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate | 20.0 | 0 | 1 |
| The Impact of Medicare Part D on Out-of-Pocket Costs for Prescription Drugs, Medication Utilization, Health Resource Utilization, and Preference-Based Health Utility | 20.0 | 0 | 1 |
| Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents | 20.0 | 0 | 1 |
| Birth after the reimplantation of a human embryo | 20.0 | 0 | 1 |
| Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients | 20.0 | 0 | 1 |
| Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure | 20.0 | 0 | 1 |
| Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care | 20.0 | 0 | 1 |
| Similarin vitromaturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients | 20.0 | 0 | 1 |
| Successful treatment of cervical stenosis with hysteroscopic canalization before embryo transfer in patients undergoing IVF: a case series | 20.0 | 0 | 1 |
| Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed? | 20.0 | 0 | 1 |
| Serum progestagen-associated endometrial protein (PEP) levels in conception versus nonconception cycles following in vitro fertilization-embryo transfer | 20.0 | 0 | 1 |
| Physician consideration of patients' out-of-pocket costs in making common clinical decisions | 20.0 | 0 | 1 |
| In-vitro cervical mucus-sperm penetration tests and outcome of infertility treatments in couples with repeatedly negative post-coital tests | 20.0 | 0 | 1 |
| Is a male infertility clinic of any use? | 20.0 | 0 | 1 |
| Cost comparison of parenteral estrogen and conventional hormonal treatment in patients with prostatic cancer | 20.0 | 0 | 1 |
| Semen quality and sperm DNA damage in relation to urinary bisphenol A among men from an infertility clinic | 20.0 | 0 | 1 |
| Urinary bisphenol A concentrations and association within vitrofertilization outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| Personal power-frequency magnetic field exposure in women recruited at an infertility clinic: association with physical activity and temporal variability | 20.0 | 0 | 1 |
| Impact of men's dairy intake on assisted reproductive technology outcomes among couples attending a fertility clinic | 20.0 | 0 | 1 |
| Urinary paraben concentrations and in vitro fertilization outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| Dietary folate intake and modification of the association of urinary bisphenol A concentrations with in vitro fertilization outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| Q28392006 | 20.0 | 0 | 1 |
| Urinary Paraben Concentrations and Ovarian Aging among Women from a Fertility Center | 20.0 | 0 | 1 |
| Hair mercury concentrations and in vitro fertilization (IVF) outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| Parental contributions to early embryo development: influences of urinary phthalate and phthalate alternatives among couples undergoing IVF treatment | 20.0 | 0 | 1 |
| PERSONAL MEASURES OF POWER-FREQUENCY MAGNETIC FIELD EXPOSURE AMONG MEN FROM AN INFERTILITY CLINIC: DISTRIBUTION, TEMPORAL VARIABILITY AND CORRELATION WITH THEIR FEMALE PARTNERS' EXPOSURE | 20.0 | 0 | 1 |
| Paternal Urinary Concentrations of Parabens and Other Phenols in Relation to Reproductive Outcomes among Couples from a Fertility Clinic | 20.0 | 0 | 1 |
| Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap | 20.0 | 0 | 1 |
| Ontogeny of adenosine deaminase in the mouse decidua and placenta: immunolocalization and embryo transfer studies | 20.0 | 0 | 1 |
| Effect of sperm DNA fragmentation on clinical outcome of frozen-thawed embryo transfer and on blastocyst formation | 20.0 | 0 | 1 |
| Correction: Changes in Drug Utilization during a Gap in Insurance Coverage: An Examination of the Medicare Part D Coverage Gap | 20.0 | 0 | 1 |
| Congenital Malformations among Babies Born Following Letrozole or Clomiphene for Infertility Treatment | 20.0 | 0 | 1 |
| Mammalian fertility preservation through cryobiology: value of classical comparative studies and the need for new preservation options | 20.0 | 0 | 1 |
| Out-of-pocket cost of managing sick newborns in Enugu, southeast Nigeria | 20.0 | 0 | 1 |
| Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials | 20.0 | 0 | 1 |
| Increasing health insurance costs and the decline in insurance coverage | 20.0 | 0 | 1 |
| The effect of intrauterine human chorionic gonadotropin injection before embryo transfer on the implantation and pregnancy rate in infertile patients: A randomized clinical trial | 20.0 | 0 | 1 |
| The effect of endometrial injury on pregnancy rate in frozen-thawed embryo transfer: A randomized control trial | 20.0 | 0 | 1 |
| Reproductive Endocrinology and Infertility | 20.0 | 0 | 1 |
| GIFT The Hope for Future Infertility Treatment | 20.0 | 0 | 1 |
| Cost estimate of electricity produced by TPV | 20.0 | 0 | 1 |
| Is a Male Infertility Clinic of Any Use? | 20.0 | 0 | 1 |
| Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention | 20.0 | 0 | 1 |
| William F. Crowley | 20.0 | 0 | 1 |
| More research, more responsibility: the expansion of duty to warn in cancer patients considering fertility preservation | 20.0 | 0 | 1 |
| Psychiatric aspects of infertility and infertility treatments | 20.0 | 0 | 1 |
| Hysteroscopic polypectomy prior to infertility treatment: A cost analysis and systematic review | 20.0 | 0 | 1 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection. | 20.0 | 0 | 1 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation. | 20.0 | 0 | 1 |
| Fertility preservation in women with borderline ovarian tumours. | 20.0 | 0 | 1 |
| Where are oncofertility and fertility preservation treatments heading in 2016? | 20.0 | 0 | 1 |
| Pregnancy after oocyte donation in 45, X Turner syndrome women, complicated by gestational diabetes and polyhydramnios. Case report and mini-review of literature | 20.0 | 0 | 1 |
| Cost Comparison of Outpatient Versus Inpatient Unicompartmental Knee Arthroplasty | 20.0 | 0 | 1 |
| Fertility Care Multan | 20.0 | 0 | 1 |
| Midwest Fertility Specialists | 20.0 | 0 | 1 |
| Southeastern Fertility Center | 20.0 | 0 | 1 |
| Fertility Preservation after a Cancer Diagnosis: A Systematic Review of Adolescents', Parents', and Providers' Perspectives, Experiences, and Preferences | 20.0 | 0 | 1 |
| Fertility Center of Las Vegas | 20.0 | 0 | 1 |
| A cost comparison of heart transplantation versus alternative operations for cardiomyopathy | 20.0 | 0 | 1 |
| Predictors of participant retention in infertility treatment trials | 20.0 | 0 | 1 |
| Advancement of male health is dependent upon updates to insurance coverage for infertility in the United States | 20.0 | 0 | 1 |
| Infertile couples' experience of family stress while women are hospitalized for ovarian hyperstimulation syndrome during infertility treatment | 20.0 | 0 | 1 |
| ‘An ounce of prevention is worth a pound of cure’: the case for and against GnRH-agonist for fertility preservation | 20.0 | 0 | 1 |
| Randomized Trial of Harp Therapy During In Vitro Fertilization–Embryo Transfer | 20.0 | 0 | 1 |
| Distributive justice and infertility treatment in Canada | 20.0 | 0 | 1 |
| The impact of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT) on short term diabetic medication costs | 20.0 | 0 | 1 |
| Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study | 20.0 | 0 | 1 |
| First-trimester diagnosis and management of Cesarean scar pregnancies after in vitro fertilization-embryo transfer: a retrospective clinical analysis of 12 cases | 20.0 | 0 | 1 |
| Prevention of prematurity by single embryo transfer | 20.0 | 0 | 1 |
| A cost comparison of electronic and hybrid data collection systems in Ontario during pandemic and seasonal influenza vaccination campaigns | 20.0 | 0 | 1 |
| Health insurance coverage for mental illness | 20.0 | 0 | 1 |
| A cost comparison of two strategies for treating stage IB2 cervical cancer | 20.0 | 0 | 1 |
| Prior authorization made simple. | 20.0 | 0 | 1 |
| A retrospective analysis of the revocation of prior authorization restrictions and the use of antidepressant medications for treating major depressive disorder | 20.0 | 0 | 1 |
| Observational study of the development and evaluation of a fertility preservation patient decision aid for teenage and adult women diagnosed with cancer: the Cancer, Fertility and Me research protocol | 20.0 | 0 | 1 |
| Immunoregulation of follicular renewal, selection, POF, and menopause in vivo, vs. neo-oogenesis in vitro, POF and ovarian infertility treatment, and a clinical trial | 20.0 | 0 | 1 |
| Improved pregnancy and birth rates with routine application of nonsurgical embryo transfer | 20.0 | 0 | 1 |
| Engaged Patients Will Need Comparative Physician-Level Quality Data And Information About Their Out-Of-Pocket Costs | 20.0 | 0 | 1 |
| Obligatory versus elective single embryo transfer in in vitro fertilization. A population-based analysis of data from the U.K. Human Fertilisation and Embryology Authority | 20.0 | 0 | 1 |
| Cultivation of the notochord of a Balanoglossus species in diffusion chambers | 20.0 | 0 | 1 |
| Schur, C.L., et al., Health insurance coverage of persons with HIV-related illness: data from the ACSUS Screener. AIDS Cost and Services Utilization Survey (ACSUS) Report No. 2. AHCPR Pub. No. 94-0009 Rockville, MD: Agency for Health Care Policy and | 20.0 | 0 | 1 |
| Cost comparison of tinzaparin versus enoxaparin as deep venous thrombosis prophylaxis in spinal cord injury: preliminary data | 20.0 | 0 | 1 |
| Establishment of lipiodol as a fertility treatment – Prospective study of the complete innovative treatment data set | 20.0 | 0 | 1 |
| Trends in health insurance coverage: a look at early 2001 data | 20.0 | 0 | 1 |
| Practice characteristics and prior authorization costs: secondary analysis of data collected by SALT-Net in 9 central New York primary care practices | 20.0 | 0 | 1 |
| The merits of blastocyst versus cleavage stage embryo transfer: a Cochrane review | 20.0 | 0 | 1 |
| Data on 249 cases of malignant pneumoconioses deceased inthe first ten years of insurance coverage (1943-1953). | 20.0 | 0 | 1 |
| A cost comparison of long-acting insulin analogs vs NPH insulin-based treatment in patients with type 2 diabetes using routinely collected primary care data from the UK | 20.0 | 0 | 1 |
| Assessing the validity of insurance coverage data in hospital discharge records: California OSHPD data | 20.0 | 0 | 1 |
| The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study | 20.0 | 0 | 1 |
| Cost comparison of auditory brainstem response versus magnetic resonance imaging screening of acoustic neuroma. | 20.0 | 0 | 1 |
| Gaps in the evidence for fertility treatment-an analysis of the Cochrane Menstrual Disorders and Subfertility Group database | 20.0 | 0 | 1 |
| Supporting health insurance expansion: do electronic health records have valid insurance verification and enrollment data? | 20.0 | 0 | 1 |
| Improving data collection processes for routine evaluation of treatment cost-effectiveness | 20.0 | 0 | 1 |
| Low health literacy associated with higher medication costs in patients with type 2 diabetes mellitus: Evidence from matched survey and health insurance data. | 20.0 | 0 | 1 |
| Laparoscopic management of hydrosalpinges before in vitro fertilization-embryo transfer: salpingectomy versus proximal tubal occlusion | 20.0 | 0 | 1 |
| The association between health insurance coverage and diabetes care; data from the 2000 Behavioral Risk Factor Surveillance System | 20.0 | 0 | 1 |
| Demographics, insurance coverage, and utilization of medical services in newly diagnosed prostate cancer: data from caPSURE. | 20.0 | 0 | 1 |
| Risk of preterm birth after blastocyst embryo transfer: a large population study using contemporary registry data from Australia and New Zealand. | 20.0 | 0 | 1 |
| Health insurance coverage and health-related quality of life: analysis of 2000 Medical Expenditure Panel Survey data. | 20.0 | 0 | 1 |
| Decision-making about fertility preservation—qualitative data on young cancer patients’ attitudes and needs | 20.0 | 0 | 1 |
| The Great Recession of 2007-2009 and Public Insurance Coverage for Children in Alabama: Enrollment and Claims Data from 1999-2011. | 20.0 | 0 | 1 |
| Effect of physician specialist alternative payment plans on administrative health data in Calgary: a validation study | 20.0 | 0 | 1 |
| Could induced apoptosis of human granulosa cells predict in vitro fertilization-embryo transfer outcome? A preliminary study of 25 women. | 20.0 | 0 | 1 |
| The German Middleway as Precursor for Single Embryo Transfer. A Retrospective Data-analysis of the Düsseldorf University Hospital's Interdisciplinary Fertility Centre - UniKiD. | 20.0 | 0 | 1 |
| Health insurance coverage, neonatal mortality and caesarean section deliveries: an analysis of vital registration data in Colombia | 20.0 | 0 | 1 |
| The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data | 20.0 | 0 | 1 |
| Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients | 20.0 | 0 | 1 |
| Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome | 20.0 | 0 | 1 |
| Effect of a single dose of ibuprofen lysinate before embryo transfer on pregnancy rates in cows | 20.0 | 0 | 1 |
| A two- versus three-embryo transfer: the oocyte donation model | 20.0 | 0 | 1 |
| Cost comparison of two implantable cardiac monitors in two different settings: Reveal XT in a catheterization laboratory vs. Reveal LINQ in a procedure room | 20.0 | 0 | 1 |
| Conceptual design and cost estimate for a modified hemoglobin production plant | 20.0 | 0 | 1 |
| A randomized double-blind controlled study of the efficacy of laser-assisted hatching on implantation and pregnancy rates of frozen-thawed embryo transfer at the cleavage stage. | 20.0 | 0 | 1 |
| Risk assessment of mouse hepatitis virus infection via in vitro fertilization and embryo transfer by the use of zona-intact and laser-microdissected oocytes | 20.0 | 0 | 1 |
| Human papillomavirus: burden of illness and treatment cost considerations | 20.0 | 0 | 1 |
| Cost comparison of low-field (0.23 T) MRI-guided laser ablation and surgery in the treatment of osteoid osteoma | 20.0 | 0 | 1 |
| Pregnancy outcomes after assisted reproductive technology | 20.0 | 0 | 1 |
| Meeting the need for state-level estimates of health insurance coverage: use of State and Federal survey data | 20.0 | 0 | 1 |
| Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario Health Insurance Plan | 20.0 | 0 | 1 |
| Laser assisted hatching in good prognosis patients undergoing in vitro fertilization-embryo transfer: a randomized controlled trial | 20.0 | 0 | 1 |
| Effect of passive uterine straightening during embryo transfer: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Surgery insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer | 20.0 | 0 | 1 |
| Randomized double-blind comparison of laser zona pellucida thinning and breaching in frozen-thawed embryo transfer at the cleavage stage. | 20.0 | 0 | 1 |
| Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Human spermatozoa ultrastructure assessment in the infertility treatment by assisted reproduction technique | 20.0 | 0 | 1 |
| Effect of the size of zona pellucida opening by laser assisted hatching on clinical outcome of frozen cleaved embryos that were cultured to blastocyst after thawing in women with multiple implantation failures of embryo transfer: a retrospective stu | 20.0 | 0 | 1 |
| Private insurance coverage of laser acupuncture | 20.0 | 0 | 1 |
| Impact of assisted hatching on fresh and frozen-thawed embryo transfer cycles: a prospective, randomized study | 20.0 | 0 | 1 |
| Outpatient hysteroscopy and subsequent IVF cycle outcome: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Cost‐effectiveness Analysis and Insurance Coverage: Solving a Puzzle | 20.0 | 0 | 1 |
| Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents | 20.0 | 0 | 1 |
| GnRH-agonists in fertility preservation | 20.0 | 0 | 1 |
| Determinants of non attendance to mammography program in a region with high voluntary health insurance coverage | 20.0 | 0 | 1 |
| Child health insurance coverage: a survey among temporary and permanent residents in Shanghai | 20.0 | 0 | 1 |
| Controversies in clinical embryology: embryo selection towards single embryo transfer - 16 July 2008, University of Manchester | 20.0 | 0 | 1 |
| Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer | 20.0 | 0 | 1 |
| Effect of stem cell activation, culture media of manipulated embryos, and site of embryo transfer in the production of F0 embryonic stem cell mice. | 20.0 | 0 | 1 |
| Multifetal gestations with assisted reproductive technique before the single-embryo transfer legislation: obstetric, neonatal outcomes and congenital anomalies | 20.0 | 0 | 1 |
| Cost Comparison Model: Blended eLearning versus traditional training of community health workers | 20.0 | 0 | 1 |
| Artificial insemination and use of a sperm bank at the fertility clinic of the C.H.U.L. (Centre hospitalier de l'université Larval) | 20.0 | 0 | 1 |
| Incorporating natural variation into IVF clinic league tables: The Expected Rank | 20.0 | 0 | 1 |
| Recent data on health insurance coverage associated with the economic downturn in North Carolina | 20.0 | 0 | 1 |
| Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data | 20.0 | 0 | 1 |
| Embryo recovery rate and recipients' pregnancy rate after nonsurgical embryo transfer in donkeys | 20.0 | 0 | 1 |
| Effect of laser zona thinning on vitrified-warmed embryo transfer at the cleavage stage: a prospective, randomized study | 20.0 | 0 | 1 |
| Embryo transfer in rabbits | 20.0 | 0 | 1 |
| Cross-border fertility care--International Committee Monitoring Assisted Reproductive Technologies global survey: 2006 data and estimates | 20.0 | 0 | 1 |
| Reproductive endocrinology: quo vadis? Scientific, social, ethical and economic challenges. | 20.0 | 0 | 1 |
| Treatment Cost of Acute Gonococcal Infections: Estimates From Employer-Sponsored Private Insurance Claims Data in the United States, 2003–2007 | 20.0 | 0 | 1 |
| Preparation of endometrium for egg donation | 20.0 | 0 | 1 |
| Primate Follicular Development and Oocyte Maturation In Vitro | 20.0 | 0 | 1 |
| Dairy intake and semen quality among men attending a fertility clinic | 20.0 | 0 | 1 |
| Increasing and decreasing factors of hope in infertile women with failure in infertility treatment: A phenomenology study | 20.0 | 0 | 1 |
| Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization/ intracytoplasmic sperm injection: A randomized clinical trial | 20.0 | 0 | 1 |
| Effects of Type of Health Insurance Coverage on Colorectal Cancer Survival in Puerto Rico: A Population-Based Study | 20.0 | 0 | 1 |
| Package pricing roils cardiac, orthopedic services. | 20.0 | 0 | 1 |
| Reproductive endocrinology: maternal cholestasis and offspring metabolic abnormalities | 20.0 | 0 | 1 |
| The impact of atosiban on pregnancy outcomes in women undergoing in vitro fertilization-embryo transfer: A meta-analysis | 20.0 | 0 | 1 |
| Assessment of endometrial and ovarian characteristics using three dimensional power Doppler ultrasound to predict response in frozen embryo transfer cycles | 20.0 | 0 | 1 |
| HCFA proposes outpatient prospective payment plan | 20.0 | 0 | 1 |
| Elective single embryo transfer following in vitro fertilization | 20.0 | 0 | 1 |
| In-hospital cost comparison between percutaneous pulmonary valve implantation and surgery | 20.0 | 0 | 1 |
| Personal care product use and urinary phthalate metabolite and paraben concentrations during pregnancy among women from a fertility clinic | 20.0 | 0 | 1 |
| Retrospective clinical analysis of two artificial shrinkage methods applied prior to blastocyst vitrification on the outcome of frozen embryo transfer | 20.0 | 0 | 1 |
| Serum progesterone concentration on day of embryo transfer in donor oocyte cycles | 20.0 | 0 | 1 |
| Childbirth and fertility preservation in childhood and adolescent cancer patients: a second national survey of Japanese pediatric endocrinologists | 20.0 | 0 | 1 |
| Evidence of a causal link between health outcomes, insurance coverage, and a policy to expand access: experimental data from children in the Philippines | 20.0 | 0 | 1 |
| Can letrozole plus HMG protocol improve pregnancy outcomes in frozen-thawed embryo transfer? An RCT | 20.0 | 0 | 1 |
| What factors are important for successful embryo transfer after in-vitro fertilization? | 20.0 | 0 | 1 |
| Can medical insurance coverage reduce disparities of income in elderly patients requiring long-term care? The case of the People&rsquo;s Republic of China | 20.0 | 0 | 1 |
| Health insurance coverage for alcoholism: a review of costs and utilization | 20.0 | 0 | 1 |
| A review of progress in development of health insurance coverage for alcoholism treatment | 20.0 | 0 | 1 |
| Private financing options for long-term care | 20.0 | 0 | 1 |
| The LIFESTYLE study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial | 20.0 | 0 | 1 |
| Live birth after fresh embryo transfer vs elective embryo cryopreservation/frozen embryo transfer in women with polycystic ovary syndrome undergoing IVF (FreFro-PCOS): study protocol for a multicenter, prospective, randomized controlled clinical tri | 20.0 | 0 | 1 |
| Status of insurance coverage for organ transplants in the United States: a review of recent surveys | 20.0 | 0 | 1 |
| Does insurance coverage dictate mental health care? | 20.0 | 0 | 1 |
| Court invalidates parts of Medicare ESRD payment plan | 20.0 | 0 | 1 |
| Beyond insurance coverage: usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003-2006 National Health and Nutrition Examination Survey | 20.0 | 0 | 1 |
| Fertility Preservation in Cancer Patients: In Vivo and In Vitro Options | 20.0 | 0 | 1 |
| Attitudes of Infertile Couples, Fertility Clinic Staff and Researchers toward Personhood of The Human Embryo in Iran | 20.0 | 0 | 1 |
| The New Destination Disadvantage: Disparities in Hispanic Health Insurance Coverage Rates in Metropolitan and Nonmetropolitan New and Established Destinations | 20.0 | 0 | 1 |
| Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates | 20.0 | 0 | 1 |
| Is a Blanket Elective Single Embryo Transfer Policy Defensible? | 20.0 | 0 | 1 |
| Recombinant follitropin alfa/lutropin alfa in fertility treatment. | 20.0 | 0 | 1 |
| Towards single embryo transfer? Modelling clinical outcomes of potential treatment choices using multiple data sources: predictive models and patient perspectives. | 20.0 | 0 | 1 |
| Promoting the use of elective single embryo transfer in clinical practice | 20.0 | 0 | 1 |
| Fertility preservation and potential future treatment options | 20.0 | 0 | 1 |
| Heterologous Embryo Transfer: Magisterial Answers and Metaphysical Questions | 20.0 | 0 | 1 |
| Enhancing pregnant, donor oocyte recipient women's health in the infertility clinic and beyond: a phenomenological investigation of caring behaviour | 20.0 | 0 | 1 |
| Is prior authorization of topical tretinoin for acne cost effective? | 20.0 | 0 | 1 |
| Impacts of Anti-dsDNA Antibody on In Vitro Fertilization-Embryo Transfer and Frozen-Thawed Embryo Transfer. | 20.0 | 0 | 1 |
| The efficacy and adverse effects of in vitro fertilization and embryo transfer | 20.0 | 0 | 1 |
| Paying for Prevention: Challenges to Health Insurance Coverage for Biomedical HIV Prevention in the United States | 20.0 | 0 | 1 |
| Use of fertility treatment modalities in a large United States cohort of professional women. | 20.0 | 0 | 1 |
| Embryo transfer cannot delineate between the maternal pregnancy environment and germ line effects in the transgenerational transmission of disease in rats | 20.0 | 0 | 1 |
| The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients. | 20.0 | 0 | 1 |
| Ovarian hyperstimulation syndrome and benign intracranial hypertension in pregnancy after in-vitro fertilization and embryo transfer: case report | 20.0 | 0 | 1 |
| The effect of owning private long-term care insurance policies on out-of-pocket costs. | 20.0 | 0 | 1 |
| A greater number of euploid blastocysts in a given cohort predicts excellent outcomes in single embryo transfer cycles | 20.0 | 0 | 1 |
| Live birth in a 46 year old using autologous oocytes cryopreserved for a duration of 3 years: a case report documenting fertility preservation at an advanced reproductive age | 20.0 | 0 | 1 |
| Long term costs and effects of reducing the number of twin pregnancies in IVF by single embryo transfer: the TwinSing study | 20.0 | 0 | 1 |
| Reproductive endocrinology of female elasmobranchs: lessons from the little skate (Raja erinacea) and spiny dogfish (Squalus acanthias). | 20.0 | 0 | 1 |
| The demand for health insurance coverage by low-income workers: can reduced premiums achieve full coverage? | 20.0 | 0 | 1 |
| Laparoscopy vs. laparotomy for embryo transfer to produce transgenic goats (Capra hircus). | 20.0 | 0 | 1 |
| Insurance coverage and access: implications for health policy | 20.0 | 0 | 1 |
| Substance abuse treatment cost offsets vary with gender, age, and abstinence likelihood | 20.0 | 0 | 1 |
| Frozen embryo transfer prevents the detrimental effect of high estrogen on endometrium receptivity | 20.0 | 0 | 1 |
| GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles | 20.0 | 0 | 1 |
| Success of frozen embryo transfer: Does the type of gonadotropin influence the outcome? | 20.0 | 0 | 1 |
| Factors associated with the use of elective single-embryo transfer and pregnancy outcomes in the United States, 2004-2012. | 20.0 | 0 | 1 |
| Serum Progesterone Elevation Adversely Affects Cumulative Live Birth Rate in Different Ovarian Responders during In Vitro Fertilization and Embryo Transfer: A Large Retrospective Study | 20.0 | 0 | 1 |
| Current status of comprehensive chromosome screening for elective single-embryo transfer. | 20.0 | 0 | 1 |
| Desire for a child and eating disorders in women seeking infertility treatment | 20.0 | 0 | 1 |
| GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis | 20.0 | 0 | 1 |
| Fertility preservation for cancer patients: a review | 20.0 | 0 | 1 |
| Uninsured and unstably insured: the importance of continuous insurance coverage. | 20.0 | 0 | 1 |
| Uninsured status and out-of-pocket costs at midlife | 20.0 | 0 | 1 |
| The health and healthcare impact of providing insurance coverage to uninsured children: A prospective observational study | 20.0 | 0 | 1 |
| Combined analysis of endometrial thickness and pattern in predicting outcome of in vitro fertilization and embryo transfer: a retrospective cohort study | 20.0 | 0 | 1 |
| The past, present and future of reproductive endocrinology. | 20.0 | 0 | 1 |
| Current state and controversies in fertility preservation in women with breast cancer. | 20.0 | 0 | 1 |
| Validity and cost comparison of 14carbon urea breath test for diagnosis of H Pylori in dyspeptic patients | 20.0 | 0 | 1 |
| Potential liability of reproductive endocrinologists for high order multiple gestation. | 20.0 | 0 | 1 |
| Fertility treatment in HIV needs multidisciplinary team | 20.0 | 0 | 1 |
| Knowledge regarding fertility preservation in cancer patients: a population-based survey among Brazilian people during the Pink October awareness event | 20.0 | 0 | 1 |
| Treatment of Abnormal Vaginal Microbiota before Frozen Embryo Transfer: Case-Report and Minireview to Discuss the Longitudinal Treatment Efficacy of Oral Clindamycin | 20.0 | 0 | 1 |
| Clinical guide to fertility preservation in hematopoietic cell transplant recipients | 20.0 | 0 | 1 |
| Topic Update: Effects of Colorectal Cancer Treatments on Female Fertility and Potential Methods for Fertility Preservation | 20.0 | 0 | 1 |
| Number of embryos allowed in fertility treatment should be flexible | 20.0 | 0 | 1 |
| Stability and variation in employment-based health insurance coverage, 1993-1997. | 20.0 | 0 | 1 |
| Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic | 20.0 | 0 | 1 |
| Dietitian intervention improves lipid values and saves medication costs in men with combined hyperlipidemia and a history of niacin noncompliance | 20.0 | 0 | 1 |
| What is the role of nephrologists and nurses of the dialysis department in providing fertility care to CKD patients? A questionnaire study among care providers | 20.0 | 0 | 1 |
| The effect of health insurance coverage and the doctor-patient relationship on health care utilization in high poverty neighborhoods | 20.0 | 0 | 1 |
| Comprehensive assessment of serum estradiol impact on selected physiologic markers observed during in-vitro fertilization and embryo transfer cycles. | 20.0 | 0 | 1 |
| The reproductive endocrinology and behavior of Vancouver Island marmot (Marmota vancouverensis). | 20.0 | 0 | 1 |
| Effects of Nursing Care Based on Watson's Theory of Human Caring on Anxiety, Distress, And Coping, When Infertility Treatment Fails: A Randomized Controlled Trial | 20.0 | 0 | 1 |
| Active surveillance for low-risk prostate cancer compared with immediate treatment: a Canadian cost comparison | 20.0 | 0 | 1 |
| Impact of egg donation deliveries from domestic and overseas sources on maternal care: a questionnaire survey of Japanese perinatal physicians | 20.0 | 0 | 1 |
| The prospect for international regulatory interventions in embryo transfer and reproductive technologies in the next century | 20.0 | 0 | 1 |
| State of the art in pig embryo transfer | 20.0 | 0 | 1 |
| The current status of equine embryo transfer | 20.0 | 0 | 1 |
| State of the art in sheep-goat embryo transfer | 20.0 | 0 | 1 |
| Increasing Access to Oral Anticancer Medicines in Middle-Income Countries: A Case Study of Private Health Insurance Coverage in Brazil. | 20.0 | 0 | 1 |
| Reflections on the golden anniversary of the first embryo transfer to produce a calf | 20.0 | 0 | 1 |
| Enhanced or reduced fetal growth induced by embryo transfer into smaller or larger breeds alters post-natal growth and metabolism in pre-weaning horses | 20.0 | 0 | 1 |
| Pregnancy probabilities during use of the Creighton Model Fertility Care System | 20.0 | 0 | 1 |
| Women's perceptions and experiences of the challenges in the process of male infertility treatment: A qualitative study. | 20.0 | 0 | 1 |
| Reproductive endocrinology: The emotional cost of contraception | 20.0 | 0 | 1 |
| Evaluating a Collaborative Approach to Improve Prior Authorization Efficiency in the Treatment of Hepatitis C Virus | 20.0 | 0 | 1 |
| Two's company, three's a crowd for embryo transfer | 20.0 | 0 | 1 |
| Maternal Effects of Japanese Shorthorn Cows on the Growth of Embryo-transferred Japanese Black Calves in a Cow-calf Grazing System | 20.0 | 0 | 1 |
| Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience | 20.0 | 0 | 1 |
| The incidence of monozygotic twinning in assisted reproductive technology: Analysis based on results from the 2010 Japanese ART national registry | 20.0 | 0 | 1 |
| Successful testicular sperm recovery and IVF treatment in a man with Leydig cell hypoplasia | 20.0 | 0 | 1 |
| Comparison between different routes of progesterone administration as luteal phase support in infertility treatments | 20.0 | 0 | 1 |
| Bilateral primary ovarian non-Hodgkin's lymphoma and fertility preservation: 5-year follow-up | 20.0 | 0 | 1 |
| The Photosensitivity Localized in a Vitiliginous Lesion Was Associated with the Intramuscular Injections of Synthetic Progesterone during an In Vitro Fertilization-embryo Transfer | 20.0 | 0 | 1 |
| Assisted hatching of poor-quality bovine embryos increases pregnancy success rate after embryo transfer. | 20.0 | 0 | 1 |
| Health Insurance Coverage and Racial Disparities in Breast Reconstruction After Mastectomy | 20.0 | 0 | 1 |
| Socioeconomic disparities in the use and success of fertility treatments: analysis of data from a prospective cohort in the United States. | 20.0 | 0 | 1 |
| The effect of modified quarter laser-assisted zona thinning on the implantation rate per embryo in frozen/vitrified-thawed/warmed embryo transfer cycles: a prospective randomized controlled trial | 20.0 | 0 | 1 |
| A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T) | 20.0 | 0 | 1 |
| Fertility preservation in young cancer patients | 20.0 | 0 | 1 |
| Understanding financing options for PACS implementation. Picture archiving and communication systems | 20.0 | 0 | 1 |
| Prophylactic salpingectomy does not impair the ovarian response in IVF treatment | 20.0 | 0 | 1 |
| Minimal precycle testing and ongoing cycle monitoring for in vitro fertilization and fresh pre-embryo transfer do not compromise fertilization, implantation, or ongoing pregnancy rates | 20.0 | 0 | 1 |
| Comparison of clinical outcomes between fresh embryo transfers and frozen-thawed embryo transfers | 20.0 | 0 | 1 |
| Why patients seek bariatric surgery: does insurance coverage matter? | 20.0 | 0 | 1 |
| Does prayer influence the success of in vitro fertilization-embryo transfer? Report of a masked, randomized trial. | 20.0 | 0 | 1 |
| State-mandated insurance coverage is associated with the approach to hydrosalpinges before IVF | 20.0 | 0 | 1 |
| In vitro manipulation of nonhuman primate gametes for embryo production and embryo transfer | 20.0 | 0 | 1 |
| Dynamics of social health insurance development: examining the determinants of Chinese basic health insurance coverage with panel data | 20.0 | 0 | 1 |
| Partial follicular aspiration for salvaging an IVF cycle after improper hCG administration. A case report. | 20.0 | 0 | 1 |
| Will employers drop health insurance coverage because of the Affordable Care Act? | 20.0 | 0 | 1 |
| The association between community-level insurance coverage and emergency department use. | 20.0 | 0 | 1 |
| Phytoestrogens may improve the pregnancy rate in in vitro fertilization-embryo transfer cycles: a prospective, controlled, randomized trial | 20.0 | 0 | 1 |
| Embryo transfer in the dromedary camel (Camelus dromedarius) using asynchronous, meclofenamic acid-treated recipients | 20.0 | 0 | 1 |
| Pilot survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients | 20.0 | 0 | 1 |
| Fertility preservation and adolescent cancer patients: lessons from adult survivors of childhood cancer and their parents | 20.0 | 0 | 1 |
| Effect of the method of conception and embryo transfer procedure on mid-gestation placenta and fetal development in an IVF mouse model. | 20.0 | 0 | 1 |
| The effect of luteal phase progesterone supplementation on natural frozen-thawed embryo transfer cycles | 20.0 | 0 | 1 |
| Fertility Preservation for Prepubertal Girls: Update and Current Challenges | 20.0 | 0 | 1 |
| Interspecies embryo transfer in camelids: the birth of the first Bactrian camel calves (Camelus bactrianus) from dromedary camels (Camelus dromedarius). | 20.0 | 0 | 1 |
| Evaluation of clinical factors influencing pregnancy rate in frozen embryo transfer | 20.0 | 0 | 1 |
| Avoiding multiple pregnancies in ART: a plea for single embryo transfer | 20.0 | 0 | 1 |
| Racial and ethnic disparities in reproductive endocrinology and infertility | 20.0 | 0 | 1 |
| Clinical and immunologic aspects of egg donation pregnancies: a systematic review | 20.0 | 0 | 1 |
| The influence of hydrosalpinx on IVF and embryo transfer: a review | 20.0 | 0 | 1 |
| Fertility preservation in the management of gynecologic cancers | 20.0 | 0 | 1 |
| Transcervical embryo transfer in mice | 20.0 | 0 | 1 |
| Administration of luteinizing hormone releasing hormone agonist for synchronization of estrus and generation of pseudopregnancy for embryo transfer in rats | 20.0 | 0 | 1 |
| Infertility treatment: lack of consensus plagues an unregulated field | 20.0 | 0 | 1 |
| Hypnosis versus diazepam for embryo transfer: a randomized controlled study | 20.0 | 0 | 1 |
| The importance of the cleavage stage morphology evaluation for blastocyst transfer in patients with good prognosis | 20.0 | 0 | 1 |
| Case Series of Fertility Treatment in HIV-Discordant Couples (Male Positive, Female Negative): The Ontario Experience | 20.0 | 0 | 1 |
| Effect of male hepatitis B virus infection on outcomes of in vitro fertilization and embryo transfer treatment: insights from couples undergoing oocyte donation | 20.0 | 0 | 1 |
| Fertility preservation of boys undergoing anti-cancer therapy: a review of the existing situation and prospects for the future | 20.0 | 0 | 1 |
| Use and out-of-pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010. | 20.0 | 0 | 1 |
| Health insurance coverage of mothers and children (1974) | 20.0 | 0 | 1 |
| Health Insurance Coverage for Persons in HIV Care, 2006–2012 | 20.0 | 0 | 1 |
| Initial IVF-ET experience with assisted hatching performed 3 days after retrieval followed by day 5 embryo transfer | 20.0 | 0 | 1 |
| The effects of perioperative analgesia on litter size in Crl:CD1(ICR) mice undergoing embryo transfer | 20.0 | 0 | 1 |
| Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany | 20.0 | 0 | 1 |
| Predictive value of plasma human chorionic gonadotrophin beta subunit in diagnosing ectopic pregnancy after in vitro fertilisation and embryo transfer | 20.0 | 0 | 1 |
| Impact of short-term preconceptional exposure to particulate air pollution on treatment outcome in couples undergoing in vitro fertilization and embryo transfer (IVF/ET) | 20.0 | 0 | 1 |
| RETIRED: Advanced Reproductive Age and Fertility | 20.0 | 0 | 1 |
| Utero-tubal embryo transfer and vasectomy in the mouse model | 20.0 | 0 | 1 |
| Fertility preservation among the cancer patients by ovarian tissue cryopreservation, transplantation, and follicular development | 20.0 | 0 | 1 |
| Treatment cost for typhoid fever at two hospitals in Kolkata, India | 20.0 | 0 | 1 |
| Total cost comparison in relapsed/refractory multiple myeloma | 20.0 | 0 | 1 |
| Fertility preservation and GnRHa for chemotherapy: debate | 20.0 | 0 | 1 |
| Options for fertility preservation in prepubertal boys | 20.0 | 0 | 1 |
| In vivo fate mapping of cryopreserved murine ovarian grafts | 20.0 | 0 | 1 |
| Effect of delayed versus immediate embryo transfer catheter removal on pregnancy outcomes during fresh cycles | 20.0 | 0 | 1 |
| The patients' perspective on fertility care: a systematic review | 20.0 | 0 | 1 |
| Training in embryo transfer: how should it be done? | 20.0 | 0 | 1 |
| How the FMR1 gene became relevant to female fertility and reproductive medicine | 20.0 | 0 | 1 |
| Optimizing the technique of embryo transfer | 20.0 | 0 | 1 |
| Fertility preservation outcomes may differ by cancer diagnosis | 20.0 | 0 | 1 |
| Correlation of subendometrial-endometrial blood flow assessment by two-dimensional power Doppler with pregnancy outcome in frozen-thawed embryo transfer cycles | 20.0 | 0 | 1 |
| Term delivery following pyometra after in vitro fertilization and embryo transfer | 20.0 | 0 | 1 |
| In vitro technologies related to pig embryo transfer. | 20.0 | 0 | 1 |
| Viral particles of endogenous betaretroviruses are released in the sheep uterus and infect the conceptus trophectoderm in a transspecies embryo transfer model. | 20.0 | 0 | 1 |
| Fertility preservation in patients with haematological disorders: a retrospective cohort study | 20.0 | 0 | 1 |
| Use of component analyses to identify active variables in treatment packages for children with feeding disorders | 20.0 | 0 | 1 |
| Global variations in the uptake of single embryo transfer | 20.0 | 0 | 1 |
| Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation | 20.0 | 0 | 1 |
| The effect of out-of-pocket costs and financial rewards in a discrete choice experiment: an application to lifestyle programs | 20.0 | 0 | 1 |
| Private health insurance coverage for substance abuse and mental health services, 1995 to 1998 | 20.0 | 0 | 1 |
| Eight-hydroxy-2'-deoxyguanosine in granulosa cells is correlated with the quality of oocytes and embryos in an in vitro fertilization-embryo transfer program | 20.0 | 0 | 1 |
| Evaluation of client preference for function-based treatment packages | 20.0 | 0 | 1 |
| Using pretreatment and posttreatment assessments to enhance and evaluate existing treatment packages | 20.0 | 0 | 1 |
| Minimal ovarian stimulation (mini-IVF) for IVF utilizing vitrification and cryopreserved embryo transfer | 20.0 | 0 | 1 |
| Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature | 20.0 | 0 | 1 |
| Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors. | 20.0 | 0 | 1 |
| Fertility treatment, twin births, and unplanned pregnancies in women with eating disorders: findings from a population‐based birth cohort | 20.0 | 0 | 1 |
| A pilot double-blind randomised placebo-controlled dose–response trial assessing the effects of melatonin on infertility treatment (MIART): study protocol | 20.0 | 0 | 1 |
| The Effects of Parity, Breastfeeding, and Infertility Treatment on the Risk of Hereditary Breast and Ovarian Cancer: A Review | 20.0 | 0 | 1 |
| Maternal age and initial β-hCG levels predict pregnancy outcome after single vitrified-warmed blastocyst transfer | 20.0 | 0 | 1 |
| The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles | 20.0 | 0 | 1 |
| The outcome of infertility treatment in patients undergoing assisted reproductive technology after conservative therapy for endometrial cancer | 20.0 | 0 | 1 |
| Insurance coverage and outcomes of in vitro fertilization. | 20.0 | 0 | 1 |
| Ethical Problems with Infertility Treatments: Attitudes and Explanations | 20.0 | 0 | 1 |
| Use of embryo transfer and IVF to bypass effects of heat stress | 20.0 | 0 | 1 |
| Oocyte donation in infertility treatment--a review | 20.0 | 0 | 1 |
| Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes | 20.0 | 0 | 1 |
| The impact of female obesity on the outcome of fertility treatment | 20.0 | 0 | 1 |
| Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic review | 20.0 | 0 | 1 |
| Reproductive endocrinology and toxicological pathology over the life span of the female rodent | 20.0 | 0 | 1 |
| Predictors of not pursuing infertility treatment after an infertility diagnosis: examination of a prospective U.S. cohort | 20.0 | 0 | 1 |
| A brief component analysis of potential treatment packages in an outpatient clinic setting with young children | 20.0 | 0 | 1 |
| Superovulation and embryo transfer in the dairy goat | 20.0 | 0 | 1 |
| Differences in reproductive endocrinology between Asian men and Caucasian men--a literature review | 20.0 | 0 | 1 |
| Treatment cost effectiveness in acute otitis media: A watch-and-wait approach versus amoxicillin | 20.0 | 0 | 1 |
| The effects of prior authorization policies on medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states | 20.0 | 0 | 1 |
| Toward theoretical understanding of the fertility preservation decision-making process: examining information processing among young women with cancer. | 20.0 | 0 | 1 |
| Prospective Study of Fertility Concerns and Preservation Strategies in Young Women With Breast Cancer | 20.0 | 0 | 1 |
| The effects of insurance coverage and ethnicity on mammography utilization in a postmenopausal population | 20.0 | 0 | 1 |
| Fertility preservation for children treated for cancer (1): scientific advances and research dilemmas | 20.0 | 0 | 1 |
| Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents | 20.0 | 0 | 1 |
| Extracorporeal fertilization and embryo transfer in the treatment of infertility | 20.0 | 0 | 1 |
| The breadth of in vitro fertilization and embryo transfer | 20.0 | 0 | 1 |
| Outcome of cryopreserved-thawed embryo transfer in the GnRH agonist versus antagonist protocol | 20.0 | 0 | 1 |
| Varicocele and Male Factor Infertility Treatment: A New Meta-analysis and Review of the Role of Varicocele Repair | 20.0 | 0 | 1 |
| Preimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo? | 20.0 | 0 | 1 |
| Effect of insurance coverage on the relationship between asthma hospitalizations and exposure to air pollution | 20.0 | 0 | 1 |
| Delivery after intrauterine embryo transfer obtained by fertilization and oocyte culture in vitro | 20.0 | 0 | 1 |
| Difference, disparity, and disability: a comparison of health, insurance coverage, and health service use on the basis of race/ethnicity among US adults with disabilities, 2006-2008 | 20.0 | 0 | 1 |
| Psychology should list empirically supported principles of change (ESPs) and not credential trademarked therapies or other treatment packages | 20.0 | 0 | 1 |
| Efficacy of the local endometrial injury in patients who had previous failed IVF-ICSI outcome | 20.0 | 0 | 1 |
| Understanding reproducibility of human IVF traits to predict next IVF cycle outcome | 20.0 | 0 | 1 |
| Health-promoting Lifestyle and its Demographic Predictors in Infertile Couples Referred to Infertility Clinic of Tabriz Al-Zahra Hospital, 2013 | 20.0 | 0 | 1 |
| The Diagnosis and Management of Ovarian Hyperstimulation Syndrome | 20.0 | 0 | 1 |
| Sustained health-economic effects after reorganisation of a Swiss hospital emergency centre: a cost comparison study. | 20.0 | 0 | 1 |
| The association between fertility clinic performance and cycle volume: implications for public reporting of provider performance data | 20.0 | 0 | 1 |
| Ovary cryopreservation and transplantation for fertility preservation | 20.0 | 0 | 1 |
| What do patients want? Expectations and perceptions of IVF clinic information and support regarding frozen embryo disposition | 20.0 | 0 | 1 |
| Improved fertility preservation care for male patients with cancer after establishment of formalized oncofertility program | 20.0 | 0 | 1 |
| Racial and economic demographics of couples seeking infertility treatment | 20.0 | 0 | 1 |
| Pre-chemotherapy preservation of fertility in male patients with high-grade malignant bone and soft tissue tumors | 20.0 | 0 | 1 |
| Child health security in China: A survey of child health insurance coverage in diverse areas of the country | 20.0 | 0 | 1 |
| A critical review of the arguments for insurance coverage for smoking-cessation therapies. | 20.0 | 0 | 1 |
| IVF policy and global/local politics: The making of multiple-embryo transfer regulation in Taiwan | 20.0 | 0 | 1 |
| Fertility treatments, congenital malformations, fetal loss, and childhood acute leukemia: the ESCALE study (SFCE). | 20.0 | 0 | 1 |
| Cornual heterotopic pregnancy and cornual resection after in vitro fertilization/embryo transfer. A report of two cases | 20.0 | 0 | 1 |
| Two-year cost comparison of vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: are initial surgical costs misleading? | 20.0 | 0 | 1 |
| A reduction in public funding for fertility treatment--an econometric analysis of access to treatment and savings to government | 20.0 | 0 | 1 |
| The future of set (single embryo transfer) in the United States | 20.0 | 0 | 1 |
| Male fertility preservation before gonadotoxic therapies | 20.0 | 0 | 1 |
| Cumulative Inequality and Racial Disparities in Health: Private Insurance Coverage and Black/White Differences in Functional Limitations | 20.0 | 0 | 1 |
| Breast cancer in young women: special considerations in multidisciplinary care | 20.0 | 0 | 1 |
| Health Insurance Coverage and the Receipt of Specialty Treatment for Substance Use Disorders Among U.S. Adults | 20.0 | 0 | 1 |
| Parameters that predict success for natural cycle in vitro fertilization-embryo transfer | 20.0 | 0 | 1 |
| Duplicate health insurance coverage: determinants of variation across states | 20.0 | 0 | 1 |
| Paternal physical and sedentary activities in relation to semen quality and reproductive outcomes among couples from a fertility center | 20.0 | 0 | 1 |
| Health Insurance Coverage and Impact: A Survey in Three Cities in China | 20.0 | 0 | 1 |
| Which patients pursue fertility preservation treatments? A multicenter analysis of the predictors of fertility preservation in women with breast cancer | 20.0 | 0 | 1 |
| Spontaneous ovarian hyperstimulation syndrome following a thawed embryo transfer cycle | 20.0 | 0 | 1 |
| Female reproductive endocrinology at the turn of the millennium | 20.0 | 0 | 1 |
| Bed rest after embryo transfer: Is it harmful? | 20.0 | 0 | 1 |
| Health insurance coverage among disabled Medicare enrollees | 20.0 | 0 | 1 |
| Sex, lies, and insurance coverage? Insurance carrier coverage defenses for sexually transmitted disease claims | 20.0 | 0 | 1 |
| Americans' health insurance coverage, 1980-91. | 20.0 | 0 | 1 |
| Is tubal embryo transfer of any value? A meta-analysis and comparison with the Society for Assisted Reproductive Technology database | 20.0 | 0 | 1 |
| Reduction of ovarian torsion 1 week after embryo transfer in a patient with bilateral hyperstimulated ovaries | 20.0 | 0 | 1 |
| Health insurance coverage at midlife: characteristics, costs, and dynamics | 20.0 | 0 | 1 |
| Thyroglobulin autoantibodies: is there any added value in the detection of thyroid autoimmunity in women consulting for fertility treatment? | 20.0 | 0 | 1 |
| Public insurance eligibility and enrollment for special health care needs children. | 20.0 | 0 | 1 |
| Medicaid expansions and the insurance coverage of poor teenagers | 20.0 | 0 | 1 |
| The longer-term health outcomes for children born as a result of IVF treatment: Part I--General health outcomes | 20.0 | 0 | 1 |
| Recent advances in bovine reproductive endocrinology and physiology and their impact on drug delivery system design for the control of the estrous cycle in cattle. | 20.0 | 0 | 1 |
| The contribution of insurance coverage and community resources to reducing racial/ethnic disparities in access to care | 20.0 | 0 | 1 |
| The effects of state mental health parity legislation on perceived quality of insurance coverage, perceived access to care, and use of mental health specialty care | 20.0 | 0 | 1 |
| Fertility treatment and childhood cancer risk: a systematic meta-analysis | 20.0 | 0 | 1 |
| Endometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH antagonist administration | 20.0 | 0 | 1 |
| Comparison of Prior Authorization and Prospective Audit with Feedback for Antimicrobial Stewardship | 20.0 | 0 | 1 |
| Use of third generation gonadotropin-releasing hormone antagonists in in vitro fertilization-embryo transfer: a review | 20.0 | 0 | 1 |
| Family-Related Opinions and Stressful Situations Associated with Psychological Distress in Women Undergoing Infertility Treatment | 20.0 | 0 | 1 |
| Patient age, ethnicity, medical history, and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets: Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI) | 20.0 | 0 | 1 |
| Fertility preservation in gynecologic cancer | 20.0 | 0 | 1 |
| What is the optimal means of preparing the endometrium in frozen–thawed embryo transfer cycles? A systematic review and meta-analysis | 20.0 | 0 | 1 |
| The ambiguity of patient-centred practices: the case of a Dutch fertility clinic | 20.0 | 0 | 1 |
| Embryo transfer: how to ensure correct placement in utero | 20.0 | 0 | 1 |
| Monozygotic twins with discordant karyotypes following preimplantation genetic screening and single embryo transfer: case report | 20.0 | 0 | 1 |
| The inSIGHT study: costs and effects of routine hysteroscopy prior to a first IVF treatment cycle. A randomised controlled trial | 20.0 | 0 | 1 |
| Biomarker tests for the diagnosis of Alzheimer's disease: Generating evidence to inform insurance coverage determinations | 20.0 | 0 | 1 |
| Change in perceived health insurance coverage among people with multiple sclerosis | 20.0 | 0 | 1 |
| Treatment of osteoid osteoma using CT-guided radiofrequency ablation versus MR-guided laser ablation: a cost comparison. | 20.0 | 0 | 1 |
| Comparison of early pregnancy and neonatal outcomes after frozen and fresh embryo transfer in ART cycles. | 20.0 | 0 | 1 |
| Using the WHO essential medicines list to assess the appropriateness of insurance coverage decisions: a case study of the Croatian national medicine reimbursement list | 20.0 | 0 | 1 |
| Fertility treatments and multiple births in the United States | 20.0 | 0 | 1 |
| Conference consensus statement: ethical and research dilemmas for fertility preservation in children treated for cancer. | 20.0 | 0 | 1 |
| Efficacy and safety of long-acting GnRH agonists in in vitro fertilization and embryo transfer. | 20.0 | 0 | 1 |
| Unhealthy and uninsured: Exploring racial differences in health and health insurance coverage using a life table approach | 20.0 | 0 | 1 |
| Stolen twin: fascination and curiosity/twin research reports: evolution of sleep length; dental treatment of craniopagus twins; cryopreserved double embryo transfer; gender options in multiple pregnancy/current events: appendectomy in one twin; auti | 20.0 | 0 | 1 |
| Studies on reproductive endocrinology in non-human primates: application of non-invasive methods | 20.0 | 0 | 1 |
| Cryo-thawed embryo transfer: natural versus artificial cycle. A non-inferiority trial.(ANTARCTICA trial) | 20.0 | 0 | 1 |
| Gene expression and DNA-methylation of bovine pretransfer endometrium depending on its receptivity after in vitro-produced embryo transfer | 20.0 | 0 | 1 |
| Fertility preservation in breast cancer patients | 20.0 | 0 | 1 |
| Infertility treatment: access and judicial review -- R v. Sheffield Health Authority, ex parte Seale | 20.0 | 0 | 1 |
| Collection and Transfer of Preimplantation Mouse Embryos1 | 20.0 | 0 | 1 |
| The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial | 20.0 | 0 | 1 |
| Single-Embryo Transfer | 20.0 | 0 | 1 |
| Fresh versus frozen embryo transfer: backing clinical decisions with scientific and clinical evidence. | 20.0 | 0 | 1 |
| Ongoing normal pregnancy after transfer of zona-free blastocysts: implications for embryo transfer in the human | 20.0 | 0 | 1 |
| Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation | 20.0 | 0 | 1 |
| Reproductive endocrinology: functional effects of sex hormone-binding globulin variants | 20.0 | 0 | 1 |
| Embryo transfer: techniques and variables affecting success. | 20.0 | 0 | 1 |
| Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Antioxidants and infertility treatment, the role of Satureja Khuzestanica: A mini-systematic review | 20.0 | 0 | 1 |
| Three dimensional/four dimensional ultrasound-guided embryo transfer using the maximal implantation potential point | 20.0 | 0 | 1 |
| An android body fat distribution in females impairs the pregnancy rate of in-vitro fertilization-embryo transfer | 20.0 | 0 | 1 |
| Effect of heparin on the outcome of IVF treatment: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Legal issues in fertility treatment | 20.0 | 0 | 1 |
| Fertility preservation | 20.0 | 0 | 1 |
| Trends in the incidence of births and multiple births and the factors that determine the probability of multiple birth after IVF treatment | 20.0 | 0 | 1 |
| Insurance coverage of special foods needed in the treatment of phenylketonuria | 20.0 | 0 | 1 |
| Effect of Piroxicam on ART Outcome: A Pilot Study | 20.0 | 0 | 1 |
| Comparison between Conventional Blind Embryo Transfer and Embryo Transfer Based on Previously Measured Uterine Length | 20.0 | 0 | 1 |
| Age, body mass index, and number of previous trials: are they prognosticators of intra-uterine-insemination for infertility treatment? | 20.0 | 0 | 1 |
| Insurance Coverage & Whither Thou Goest for Health Information in 2012 | 20.0 | 0 | 1 |
| Primary ovarian pregnancy after donor embryo transfer: early diagnosis and laparoscopic treatment. | 20.0 | 0 | 1 |
| Social egg freezing: risk, benefits and other considerations | 20.0 | 0 | 1 |
| Factors influencing the success of embryo transfer in the pig | 20.0 | 0 | 1 |
| Recent developments in pig embryo transfer | 20.0 | 0 | 1 |
| Embryo transfer in domestic South American camelids | 20.0 | 0 | 1 |
| Neonatal outcomes after the transfer of vitrified blastocysts: closed versus open vitrification system | 20.0 | 0 | 1 |
| Handling and culture of bovine embryos: survey of media used by 26 embryo transfer companies in the USA | 20.0 | 0 | 1 |
| Embryo transfer in Bos indicus cattle | 20.0 | 0 | 1 |
| The control of follicular wave development for self-appointed embryo transfer programs in cattle | 20.0 | 0 | 1 |
| Impact of free delivery care on health facility delivery and insurance coverage in Ghana's Brong Ahafo Region | 20.0 | 0 | 1 |
| Prevalence of Frailty Indicators and Association with Socioeconomic Status in Middle-Aged and Older Adults in a Swiss Region with Universal Health Insurance Coverage: A Population-Based Cross-Sectional Study | 20.0 | 0 | 1 |
| Health insurance coverage and its impact on medical cost: observations from the floating population in China | 20.0 | 0 | 1 |
| Rare Case of Twin Pregnancy with Complete Hydatidiform Mole and Coexisting Fetus (CHMF) following Infertility Treatment | 20.0 | 0 | 1 |
| Cost comparison of MRSA screening and management – a decision tree analysis | 20.0 | 0 | 1 |
| Biochemistry and reproductive endocrinology of estrogen sulfotransferase. | 20.0 | 0 | 1 |
| Health insurance coverage, medical expenditure and coping strategy: evidence from Taiwan | 20.0 | 0 | 1 |
| Insurance Coverage of Puberty Blocker Therapies for Transgender Youth | 20.0 | 0 | 1 |
| A comparative study between cleavage stage embryo transfer at day 3 and blastocyst stage transfer at day 5 in in-vitro fertilization/intra-cytoplasmic sperm injection on clinical pregnancy rates | 20.0 | 0 | 1 |
| Comparison between oral and vaginal estrogen usage in inadequate endometrial patients for frozen-thawed blastocysts transfer | 20.0 | 0 | 1 |
| Factors influencing pregnancy rates with a combined clomiphene citrate/gonadotropin protocol for non-assisted reproductive technology fertility treatment | 20.0 | 0 | 1 |
| Preventive medical services use among community mental health patients with severe mental illness:the influence of gender and insurance coverage | 20.0 | 0 | 1 |
| Costs and insurance coverage associated with permanent mechanical cardiac assist/replacement devices in the United States | 20.0 | 0 | 1 |
| Marked improvement in clinical pregnancy rates following in vitro fertilization-embryo transfer seen when transfer technique and catheter were changed. | 20.0 | 0 | 1 |
| Cost comparison of hospital- and home-based treatment models for acute chronic obstructive pulmonary disease | 20.0 | 0 | 1 |
| Laparoscopic Oviductal Embryo Transfer and Artificial Insemination in Felids – Challenges, Strategies and Successes | 20.0 | 0 | 1 |
| Values clarification in a decision aid about fertility preservation: does it add to information provision? | 20.0 | 0 | 1 |
| A Comparative Analysis of Monthly Out-of-Pocket Costs for Patients with Breast Cancer as Compared with Other Common Cancers in Ontario, Canada | 20.0 | 0 | 1 |
| The impact of prior authorization on buprenorphine dose, relapse rates, and cost for Massachusetts Medicaid beneficiaries with opioid dependence | 20.0 | 0 | 1 |
| Cost comparison analysis of open versus laparoscopic distal pancreatectomy | 20.0 | 0 | 1 |
| Live birth sex ratio after in vitro fertilization and embryo transfer in China--an analysis of 121,247 babies from 18 centers | 20.0 | 0 | 1 |
| May doctors refuse infertility treatments to gay patients? | 20.0 | 0 | 1 |
| Communication and coping as predictors of fertility problem stress: cohort study of 816 participants who did not achieve a delivery after 12 months of fertility treatment | 20.0 | 0 | 1 |
| Fertility treatments, maternal intelligence, and child cognition | 20.0 | 0 | 1 |
| Prostasome membrane associated enzyme activities and semen parameters in men attending an infertility clinic | 20.0 | 0 | 1 |
| A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent | 20.0 | 0 | 1 |
| Effect of glucose concentration during in vitro culture of mouse embryos on development to blastocyst, success of embryo transfer, and litter sex ratio | 20.0 | 0 | 1 |
| Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation | 20.0 | 0 | 1 |
| Management of ureteral calculi: a cost comparison and decision making analysis | 20.0 | 0 | 1 |
| The feasibility and efficacy of gonadotropin-releasing hormone agonists for prevention of chemotherapy induced ovarian failure in patient with gynecological malignancies | 20.0 | 0 | 1 |
| Value of Early Referral to Fertility Preservation in Young Women With Breast Cancer | 20.0 | 0 | 1 |
| The presence of multiple gestational sacs confers a higher live birth rate in women with infertility who achieve a positive pregnancy test after fresh and frozen embryo transfer: a retrospective local cohort | 20.0 | 0 | 1 |
| Complementary and alternative medicine utilization by a sample of infertile couples in Jordan for infertility treatment: clinics-based survey. | 20.0 | 0 | 1 |
| Effect of vitamin D insufficiency treatment on fertility outcomes in frozen-thawed embryo transfer cycles: A randomized clinical trial | 20.0 | 0 | 1 |
| Physical activity and semen quality among men attending an infertility clinic | 20.0 | 0 | 1 |
| Costs of infertility treatment: results from an 18-month prospective cohort study | 20.0 | 0 | 1 |
| Cumulative live birth rate after two single frozen embryo transfers (eSFET) versus a double frozen embryo transfer (DFET) with cleavage stage embryos: a retrospective cohort study. | 20.0 | 0 | 1 |
| Does IVF cleavage stage embryo quality affect pregnancy complications and neonatal outcomes in singleton gestations after double embryo transfers? | 20.0 | 0 | 1 |
| Concurrent ovarian and ipsilateral tubal ectopic pregnancies after a double embryo transfer: a case report | 20.0 | 0 | 1 |
| Does the Number of Oocytes Retrieved Influence Pregnancy after Fresh Embryo Transfer? | 20.0 | 0 | 1 |
| The green grass on the other side: crossing borders to obtain infertility treatment | 20.0 | 0 | 1 |
| Insurance coverage policies for personalized medicine | 20.0 | 0 | 1 |
| Comparing patients' and clinicians' perceptions of elective single embryo transfer using the attitudes to a twin IVF pregnancy scale (ATIPS) | 20.0 | 0 | 1 |
| Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost | 20.0 | 0 | 1 |
| Oocyte Cryopreservation for Fertility Preservation in Postpubertal Female Children at Risk for Premature Ovarian Failure Due to Accelerated Follicle Loss in Turner Syndrome or Cancer Treatments | 20.0 | 0 | 1 |
| Fertility preservation via photodynamic therapy in young patients with early-stage uterine endometrial cancer: a long-term follow-up study. | 20.0 | 0 | 1 |
| Manipulating ovarian aging: A new frontier in fertility preservation | 20.0 | 0 | 1 |
| Deep intrauterine insemination and embryo transfer in pigs. | 20.0 | 0 | 1 |
| Cryopreservation of pig embryos: adaptation of vitrification technology for embryo transfer. | 20.0 | 0 | 1 |
| In vitro fertilisation and embryo transfer for bilateral salpingectomies results in a ruptured ovarian ectopic pregnancy due to a tubal stump fistula: a case report and review of the literature | 20.0 | 0 | 1 |
| Optimizing the embryo transfer technique | 20.0 | 0 | 1 |
| Prospective study of depression and anxiety in female fertility preservation and infertility patients | 20.0 | 0 | 1 |
| Effect of cell phone usage on semen analysis in men attending infertility clinic: an observational study | 20.0 | 0 | 1 |
| Risks of transmissible diseases in relation to embryo transfer. | 20.0 | 0 | 1 |
| Rendez-vous in the oviduct: implications for superovulation and embryo transfer. | 20.0 | 0 | 1 |
| Causal ACTH-Depot Therapy during Pregnancies following Infertility Treatment | 20.0 | 0 | 1 |
| Fertility Preservation in Reproductive Age Women with Cancer | 20.0 | 0 | 1 |
| Interstitial pregnancy after in vitro fertilization and embryo transfer following bilateral salpingectomy: report of two cases and literature review | 20.0 | 0 | 1 |
| Preconception counseling in couples undergoing fertility treatment | 20.0 | 0 | 1 |
| In high responding patients undergoing an initial IVF cycle, elevated estradiol on the day of hCG has no effect on live birth rate. | 20.0 | 0 | 1 |
| Association Between Prior Authorization for Medications and Health Service Use by Medicaid Patients With Bipolar Disorder | 20.0 | 0 | 1 |
| Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion | 20.0 | 0 | 1 |
| Glycodelin in reproductive endocrinology and hormone-related cancer | 20.0 | 0 | 1 |
| Pregnancy Prediction in Single Embryo Transfer Cycles after ICSI Using QPCR: Validation in Oocytes from the Same Cohort | 20.0 | 0 | 1 |
| Clinical utility of ambulatory blood pressure: perspectives for national insurance coverage | 20.0 | 0 | 1 |
| Incorporating fertility preservation into the care of young oncology patients | 20.0 | 0 | 1 |
| Do polymorphic variants of chromosomes affect the outcome of in vitro fertilization and embryo transfer treatment? | 20.0 | 0 | 1 |
| Embryo transfers between C57BL/6J and DBA/2J mice: Examination of a maternal effect on ethanol teratogenesis | 20.0 | 0 | 1 |
| Treatment-independent pregnancy after in vitro fertilization and embryo transfer trial | 20.0 | 0 | 1 |
| Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation | 20.0 | 0 | 1 |
| Effect of autoimmune thyroid disease in older euthyroid infertile woman during the first 35 days of an IVF cycle. | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted conception. | 20.0 | 0 | 1 |
| Cost comparison between uterine-sparing fibroid treatments one year following treatment | 20.0 | 0 | 1 |
| Infertility treatment targeted as Ontario delists services | 20.0 | 0 | 1 |
| Trans-fatty acid levels in sperm are associated with sperm concentration among men from an infertility clinic. | 20.0 | 0 | 1 |
| Risk of breast cancer following fertility treatment—A registry based cohort study of parous women in Norway | 20.0 | 0 | 1 |
| Fertility preservation in women with cancer. | 20.0 | 0 | 1 |
| Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update | 20.0 | 0 | 1 |
| Consensus on infertility treatment related to polycystic ovary syndrome. | 20.0 | 0 | 1 |
| Research in human in-vitro fertilisation and embryo transfer | 20.0 | 0 | 1 |
| Warning: Google Can Be Hazardous to Your Health: Fertility Preservation Is an Important Part of Cancer Care | 20.0 | 0 | 1 |
| Participation in Investigational Fertility Preservation Research: A Feminist Research Ethics Approach | 20.0 | 0 | 1 |
| One-stop endoscopy-based infertility clinic | 20.0 | 0 | 1 |
| Out-of-pocket costs for childhood stroke: the impact of chronic illness on parents' pocketbooks | 20.0 | 0 | 1 |
| Equity in private insurance coverage for substance abuse: a perspective on parity | 20.0 | 0 | 1 |
| Fertility preservation and management of gonadal failure associated with lymphoma therapy | 20.0 | 0 | 1 |
| The Effect of Single Embryo Transfer on Perinatal Outcomes in Japan | 20.0 | 0 | 1 |
| Exposure to environmental toxins in males seeking infertility treatment: a case-controlled study. | 20.0 | 0 | 1 |
| Projected Cost Comparison of Trabectome, iStent, and Endoscopic Cyclophotocoagulation Versus Glaucoma Medication in the Ontario Health Insurance Plan | 20.0 | 0 | 1 |
| SOGC clinical practice guidelines. Hirsutism: evaluation and treatment | 20.0 | 0 | 1 |
| Uncomplicated pregnancy and normal singleton delivery after surgical excision of heterotopic (cornual) pregnancy following in vitro fertilization/embryo transfer | 20.0 | 0 | 1 |
| Luteal phase support in infertility treatment: a meta-analysis of the randomized trials | 20.0 | 0 | 1 |
| Insurance coverage and subsequent utilization of complementary and alternative medicine providers | 20.0 | 0 | 1 |
| Efficacy, Safety, and Out-of-pocket Costs are the Most Important Factors to Patients in Choosing a Psoriasis Therapy | 20.0 | 0 | 1 |
| Pronuclear embryo cryopreservation experience: outcomes for reducing the risk of ovarian hyperstimulation syndrome and for fertility preservation in cancer patients | 20.0 | 0 | 1 |
| Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer | 20.0 | 0 | 1 |
| "Now we feel like we did everything we could": A qualitative study into the experiences of Dutch patients who travelled to Belgium for infertility treatment | 20.0 | 0 | 1 |
| Implementation of hysteroscopy in an infertility clinic: The one-stop uterine diagnosis and treatment | 20.0 | 0 | 1 |
| In Search of Better Spermatogonial Preservation by Supplementation of Cryopreserved Human Immature Testicular Tissue Xenografts with N-acetylcysteine and Testosterone | 20.0 | 0 | 1 |
| Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience | 20.0 | 0 | 1 |
| Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterin | 20.0 | 0 | 1 |
| A randomised controlled trial of a preconceptional dietary intervention in women undergoing IVF treatment (PREPARE trial) | 20.0 | 0 | 1 |
| The Role of a Patient Navigator in Fertility Preservation | 20.0 | 0 | 1 |
| For the Sake of Consistency and Fairness: Why Insurance Companies Should Cover Fertility Preservation Treatment for Iatrogenic Infertility | 20.0 | 0 | 1 |
| Discussing Fertility Preservation with Breast Cancer Patients | 20.0 | 0 | 1 |
| Choosing Life When Facing Death: Understanding Fertility Preservation Decision-Making for Cancer Patients | 20.0 | 0 | 1 |
| Reproductive ‘Choice’ and Egg Freezing | 20.0 | 0 | 1 |
| Healthcare provider perspectives on fertility preservation for cancer patients. | 20.0 | 0 | 1 |
| Semen Analysis: A Review of Samples from 225 Men Seen at an Infertility Clinic | 20.0 | 0 | 1 |
| Out of pocket cost comparison between Caucasian and minority breast cancer survivors in the Breast Cancer Education Intervention (BCEI) | 20.0 | 0 | 1 |
| Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece | 20.0 | 0 | 1 |
| Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer. | 20.0 | 0 | 1 |
| Follicular fluid lipid fingerprinting from women with PCOS and hyper response during IVF treatment | 20.0 | 0 | 1 |
| Morphokinetic analysis of cleavage stage embryos and its relationship to aneuploidy in a retrospective time-lapse imaging study | 20.0 | 0 | 1 |
| Survival, re-expansion and cell survival of human blastocysts following vitrification and warming using two vitrification systems | 20.0 | 0 | 1 |
| The clinical outcomes of day 3 4-cell embryos after extended in vitro culture | 20.0 | 0 | 1 |
| Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review | 20.0 | 0 | 1 |
| Identification of maternally regulated fetal gene networks in the placenta with a novel embryo transfer system in mice. | 20.0 | 0 | 1 |
| Use of complementary and alternative medicines associated with a 30% lower ongoing pregnancy/live birth rate during 12 months of fertility treatment | 20.0 | 0 | 1 |
| Survey of reasons for discontinuation from in vitro fertilization treatment among couples attending infertility clinic | 20.0 | 0 | 1 |
| Coping strategies used by patients infected with hepatitis C virus who are facing medication costs. | 20.0 | 0 | 1 |
| The PRCI study: design of a randomized clinical trial to evaluate a coping intervention for medical waiting periods used by women undergoing a fertility treatment | 20.0 | 0 | 1 |
| Two interesting cases of ovarian pregnancy after in vitro fertilization-embryo transfer and its successful laparoscopic management | 20.0 | 0 | 1 |
| Fertility preservation for female cancer patients: early clinical experience | 20.0 | 0 | 1 |
| The likelihood of live birth and multiple birth after single versus double embryo transfer at the cleavage stage: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Cost comparison between home telemonitoring and usual care of older adults: a randomized trial (Tele-ERA). | 20.0 | 0 | 1 |
| New advances in fertility preservation for pediatric cancer patients | 20.0 | 0 | 1 |
| Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial | 20.0 | 0 | 1 |
| Insuring Against Infertility: Expanding State Infertility Mandates to Include Fertility Preservation Technology for Cancer Patients | 20.0 | 0 | 1 |
| Successful fertility treatment for Klinefelter's syndrome | 20.0 | 0 | 1 |
| Health Status and Health Insurance Coverage of Women with Live-Born Infants: An Opportunity for Preventive Services After Pregnancy | 20.0 | 0 | 1 |
| Fertility preservation in female cancer patients: a single center experience | 20.0 | 0 | 1 |
| The reproductive endocrinology of the menopausal transition | 20.0 | 0 | 1 |
| Fertility treatment when the prognosis is very poor or futile | 20.0 | 0 | 1 |
| Access to fertility treatment by gays, lesbians, and unmarried persons | 20.0 | 0 | 1 |
| Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment | 20.0 | 0 | 1 |
| Insurance coverage and financial burden for families of children with special health care needs | 20.0 | 0 | 1 |
| Immediate computed tomography or admission for observation after mild head injury: cost comparison in randomised controlled trial | 20.0 | 0 | 1 |
| Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer | 20.0 | 0 | 1 |
| Clinical practice of embryo transfer | 20.0 | 0 | 1 |
| Security and cost comparison of INR self-testing and conventional hospital INR testing in patients with mechanical heart valve replacement | 20.0 | 0 | 1 |
| Out-of-pocket Costs of Disabilities and Their Association with Household Socioeconomic Status Among School-aged Children in Vietnam. | 20.0 | 0 | 1 |
| Child development and quality of parenting in lesbian families: no psychosocial indications for a-priori withholding of infertility treatment. A systematic review | 20.0 | 0 | 1 |
| In vitro production of bovine embryos and their application for embryo transfer | 20.0 | 0 | 1 |
| Improving successful pregnancies after embryo transfer | 20.0 | 0 | 1 |
| Understanding the epidemiology of fertility treatments | 20.0 | 0 | 1 |
| Health and Safety Advisory Committee (HASAC) of the International Embryo Transfer Society (IETS) has managed critical challenges for two decades | 20.0 | 0 | 1 |
| Prognostic value of first IVF cycle on success of a subsequent cycle | 20.0 | 0 | 1 |
| Live birth after in vitro fertilization and single embryo transfer in a kidney transplant patient: a case report and review of the literature | 20.0 | 0 | 1 |
| The impact of insurance coverage during insurance reform on diagnostic resolution of cancer screening abnormalities. | 20.0 | 0 | 1 |
| Survival and Cost Comparison of Kyphoplasty and Percutaneous Vertebroplasty Using German Claims Data | 20.0 | 0 | 1 |
| Racial Gaps in Child Health Insurance Coverage in Four South American Countries: The Role of Wealth, Human Capital, and Other Household Characteristics | 20.0 | 0 | 1 |
| Fertility preservation for non-medical reasons: controversial, but increasingly common. | 20.0 | 0 | 1 |
| Incomplete and inconsistent reporting of maternal and fetal outcomes in infertility treatment trials | 20.0 | 0 | 1 |
| Hysteroscopy prior to the first IVF cycle: A systematic review and meta-analysis | 20.0 | 0 | 1 |
| Infertility treatment and fertility-specific distress: A longitudinal analysis of a population-based sample of U.S. women | 20.0 | 0 | 1 |
| Prevalence and factors associated with use of herbal medicine among women attending an infertility clinic in Uganda | 20.0 | 0 | 1 |
| Thirteen -weeks ovarian pregnancy following in vitro fertilization for primary infertility treatment: A case report | 20.0 | 0 | 1 |
| Random-start GnRH antagonist for emergency fertility preservation: a self-controlled trial | 20.0 | 0 | 1 |
| Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. | 20.0 | 0 | 1 |
| Use of Versapoint to refashion the cervical canal to overcome unusually difficult embryo transfers and improve in-vitro fertilization-embryo transfer outcome: A case series | 20.0 | 0 | 1 |
| Fertility preservation and breast cancer: a review | 20.0 | 0 | 1 |
| Ovarian stimulation in patients with breast cancer | 20.0 | 0 | 1 |
| Expanding Individual Health Insurance Coverage: Are High-Risk Pools The Answer? | 20.0 | 0 | 1 |